Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NC_000019.10:g.44905579T>G	APOE		Warfarin response	VCV000619951	19	45408836	19	44905579	619951	611348	rs405509	NC_000019.10:44905578:T:G	single nucleotide variant		drug response	Aug 31, 2010	no assertion criteria provided							
NC_000019.10:g.44905579=	APOE		Coronary artery disease, severe, susceptibility to	VCV000017877	19	45408836	19	44905579	17877	32916	rs405509	NC_000019.10:44905578:T:T	single nucleotide variant		risk factor	Jun 1, 2003	no assertion criteria provided							
NM_000041.4(APOE):c.-24+47G>A	APOE	R7K	APOE-related disorder	VCV002635119	19	45409145	19	44905888	2635119	2802020	rs1246551383	NC_000019.10:44905887:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 23, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.-24+69C>G	APOE	N14K	not provided	VCV001175067	19	45409167	19	44905910	1175067	1164550	rs440446	NC_000019.10:44905909:C:G	single nucleotide variant	missense variant|intron variant	Benign		criteria provided, single submitter							
NM_000041.4(APOE):c.-24+82G>A	APOE	D19N	Familial type 3 hyperlipoproteinemia|Alzheimer disease 2	VCV001722323	19	45409180	19	44905923	1722323	1779833	rs563571689	NC_000019.10:44905922:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 24, 2022	criteria provided, conflicting classifications							
NM_000041.4(APOE):c.-23-280C>T	APOE		not provided	VCV001329718	19	45409579	19	44906322	1329718	1320402	rs769448	NC_000019.10:44906321:C:T	single nucleotide variant	intron variant	Likely benign	Jun 21, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.19G>C (p.Ala7Pro)	APOE	A33P, A7P	Cardiovascular phenotype	VCV003127999	19	45409900	19	44906643	3127999	3289887	rs1969812567	NC_000019.10:44906642:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.21G>C (p.Ala7=)	APOE		Cardiovascular phenotype	VCV003417776	19	45409902	19	44906645	3417776	3569035		NC_000019.10:44906644:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.22T>C (p.Leu8=)	APOE		Cardiovascular phenotype	VCV001789275	19	45409903	19	44906646	1789275	1850945	rs978402858	NC_000019.10:44906645:T:C	single nucleotide variant	synonymous variant	Likely benign	May 4, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.31A>T (p.Thr11Ser)	APOE	T11S, T37S	Alzheimer disease 2	VCV003779929	19	45409912	19	44906655	3779929	3895898		NC_000019.10:44906654:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.31A>G (p.Thr11Ala)	APOE	T11A, T37A	Lipoprotein glomerulopathy|Familial type 3 hyperlipoproteinemia	VCV001803815	19	45409912	19	44906655	1803815	1860840	rs144354013	NC_000019.10:44906654:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.40G>C (p.Ala14Pro)	APOE	A14P, A40P	Cardiovascular phenotype	VCV003934764	19	45409921	19	44906664	3934764	4045303		NC_000019.10:44906663:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.43+78G>A	APOE		not provided	VCV001264941	19	45410002	19	44906745	1264941	1255267	rs769449	NC_000019.10:44906744:G:A	single nucleotide variant	intron variant	Benign	Aug 30, 2018	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.43+520G>A	APOE		Warfarin response	VCV000619952	19	45410444	19	44907187	619952	611349	rs769450	NC_000019.10:44907186:G:A	single nucleotide variant	intron variant	drug response	Aug 31, 2010	no assertion criteria provided							
NM_000041.4(APOE):c.61G>A (p.Glu21Lys)	APOE	E21K, E47K	HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE5	VCV000017849	19	45411034	19	44907777	17849	32888	rs121918392	NC_000019.10:44907776:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 1, 1995	no assertion criteria provided							
NM_000041.4(APOE):c.69G>A (p.Ala23=)	APOE		Alzheimer disease 3|Alzheimer disease 2|Alzheimer disease 4|Age related macular degeneration 1|Lipoprotein glomerulopathy|Familial type 3 hyperlipoproteinemia|Sea-blue histiocyte syndrome|Cardiovascular phenotype	VCV001210034	19	45411042	19	44907785	1210034	1200081	rs111833428	NC_000019.10:44907784:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.70G>C (p.Val24Leu)	APOE	V24L, V50L	not provided	VCV003764407	19	45411043	19	44907786	3764407	3880592		NC_000019.10:44907785:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.84G>A (p.Pro28=)	APOE		Cardiovascular phenotype	VCV003231977	19	45411057	19	44907800	3231977	3385517	rs150688032	NC_000019.10:44907799:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.90C>G (p.Pro30=)	APOE		Cardiovascular phenotype	VCV001209987	19	45411063	19	44907806	1209987	1200082	rs370227413	NC_000019.10:44907805:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 4, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.91G>A (p.Glu31Lys)	APOE	E31K, E57K	Lipoprotein glomerulopathy|Sea-blue histiocyte syndrome|Familial type 3 hyperlipoproteinemia|Alzheimer disease 3|Age related macular degeneration 1|Alzheimer disease 2|not provided	VCV000440842	19	45411064	19	44907807	440842	32899	rs201672011	NC_000019.10:44907806:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2024	criteria provided, conflicting classifications							
NM_000041.4(APOE):c.98G>A (p.Arg33His)	APOE	R59H, R33H	Cardiovascular phenotype	VCV003886380	19	45411071	19	44907814	3886380	3999493		NC_000019.10:44907813:G:A	single nucleotide variant	missense variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.108C>G (p.Thr36=)	APOE		not provided	VCV001328619	19	45411081	19	44907824	1328619	1319306	rs755434388	NC_000019.10:44907823:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.109G>A (p.Glu37Lys)	APOE	E37K, E63K	Alzheimer disease 2	VCV003779927	19	45411082	19	44907825	3779927	3895896		NC_000019.10:44907824:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.114G>A (p.Trp38Ter)	APOE	W38*, W64*	not provided	VCV001320871	19	45411087	19	44907830	1320871	1311115	rs2122132512	NC_000019.10:44907829:G:A	single nucleotide variant	nonsense	Uncertain significance	Mar 10, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.116A>G (p.Gln39Arg)	APOE	Q39R, Q65R	Cardiovascular phenotype	VCV003127998	19	45411089	19	44907832	3127998	3289886	rs756353413	NC_000019.10:44907831:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.120C>T (p.Ser40=)	APOE		Cardiovascular phenotype|not provided	VCV001298772	19	45411093	19	44907836	1298772	1288634	rs373020952	NC_000019.10:44907835:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.125A>C (p.Gln42Pro)	APOE	Q42P, Q68P	Cardiovascular phenotype	VCV001762635	19	45411098	19	44907841	1762635	1817033	rs2513539611	NC_000019.10:44907840:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.127C>T (p.Arg43Cys)	APOE	R43C, R69C	Age related macular degeneration 1|Familial type 3 hyperlipoproteinemia|Sea-blue histiocyte syndrome|Lipoprotein glomerulopathy|Alzheimer disease 3|Alzheimer disease 2|Alzheimer disease 4|Cardiovascular phenotype|Lipoprotein glomerulopathy	VCV000017880	19	45411100	19	44907843	17880	32919	rs121918399	NC_000019.10:44907842:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.137T>C (p.Leu46Pro)	APOE	L46P, L72P	not provided|Alzheimer disease 4|Cardiovascular phenotype	VCV000242765	19	45411110	19	44907853	242765	32909	rs769452	NC_000019.10:44907852:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 1, 2025	criteria provided, conflicting classifications							
NM_000041.4(APOE):c.138G>A (p.Leu46=)	APOE		Cardiovascular phenotype	VCV001771513	19	45411111	19	44907854	1771513	1832709	rs761381769	NC_000019.10:44907853:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 17, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.146del (p.Gly49fs)	APOE	G49fs, G75fs	Familial type 3 hyperlipoproteinemia	VCV000017861	19	45411117	19	44907860	17861	32900	rs2122132718	NC_000019.10:44907859:GGG:GG	Deletion	frameshift variant	Pathogenic	Sep 1, 1992	no assertion criteria provided							
NM_000041.4(APOE):c.148C>A (p.Arg50Ser)	APOE	R50S, R76S	not provided	VCV000451406	19	45411121	19	44907864	451406	446145	rs11542029	NC_000019.10:44907863:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2017	criteria provided, single submitter							
NM_000041.4(APOE):c.153T>C (p.Phe51=)	APOE		Cardiovascular phenotype	VCV003934775	19	45411126	19	44907869	3934775	4045314		NC_000019.10:44907868:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 10, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.163C>T (p.Leu55=)	APOE		Cardiovascular phenotype	VCV002451019	19	45411136	19	44907879	2451019	2433278	rs2513539697	NC_000019.10:44907878:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 25, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.165G>C (p.Leu55=)	APOE		not provided|Cardiovascular phenotype	VCV003031963	19	45411138	19	44907881	3031963	3201795	rs376607258	NC_000019.10:44907880:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.167G>A (p.Arg56His)	APOE	R56H, R82H	Cardiovascular phenotype|not provided	VCV001320334	19	45411140	19	44907883	1320334	1310579	rs752790054	NC_000019.10:44907882:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.178A>G (p.Thr60Ala)	APOE	T60A, T86A	Cardiovascular phenotype	VCV000017871	19	45411151	19	44907894	17871	32910	rs28931576	NC_000019.10:44907893:A:G	single nucleotide variant	missense variant	Likely benign	Mar 6, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.190C>T (p.Gln64Ter)	APOE	Q64*, Q90*	not provided	VCV002575584	19	45411163	19	44907906	2575584	2740480	rs2513539751	NC_000019.10:44907905:C:T	single nucleotide variant	nonsense	Uncertain significance	Feb 8, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.192G>C (p.Gln64His)	APOE	Q90H, Q64H	not provided|Cardiovascular phenotype	VCV002514464	19	45411165	19	44907908	2514464	2677359	rs370594287	NC_000019.10:44907907:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.193G>T (p.Val65Leu)	APOE	V65L, V91L	Cardiovascular phenotype	VCV002451018	19	45411166	19	44907909	2451018	2433277	rs2513539761	NC_000019.10:44907908:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.201G>T (p.Glu67Asp)	APOE	E67D, E93D	Cardiovascular phenotype	VCV003417840	19	45411174	19	44907917	3417840	3569099		NC_000019.10:44907916:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.205C>T (p.Leu69=)	APOE		Cardiovascular phenotype	VCV003231962	19	45411178	19	44907921	3231962	3385502	rs139948786	NC_000019.10:44907920:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 5, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.210C>G (p.Leu70=)	APOE		Cardiovascular phenotype	VCV003934742	19	45411183	19	44907926	3934742	4045281		NC_000019.10:44907925:C:G	single nucleotide variant	synonymous variant	Likely benign	May 3, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.210C>T (p.Leu70=)	APOE		Cardiovascular phenotype	VCV001786056	19	45411183	19	44907926	1786056	1846809	rs781192562	NC_000019.10:44907925:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 19, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.214T>G (p.Ser72Ala)	APOE	S98A, S72A	Cardiovascular phenotype	VCV001786732	19	45411187	19	44907930	1786732	1844101	rs757100480	NC_000019.10:44907929:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.237-16_237-13del	APOE		not provided	VCV001210067	19	45411771 - 45411774	19	44908514 - 44908517	1210067	1200083	rs377486301	NC_000019.10:44908513:CCCGCCC:CCC	Deletion	intron variant	Likely benign	Dec 21, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.237-8G>C	APOE		APOE-related disorder	VCV003047229	19	45411782	19	44908525	3047229	3211821	rs748779489	NC_000019.10:44908524:G:C	single nucleotide variant	intron variant	Likely benign	Mar 20, 2019	no assertion criteria provided							
NM_000041.4(APOE):c.237-4G>T	APOE		Familial hypercholesterolemia	VCV002412586	19	45411786	19	44908529	2412586	2401318	rs1238363607	NC_000019.10:44908528:G:T	single nucleotide variant	intron variant	Uncertain significance	Apr 26, 2021	no assertion criteria provided							
NM_000041.4(APOE):c.237-2A>G	APOE		Familial type 3 hyperlipoproteinemia	VCV000017852	19	45411788	19	44908531	17852	32891	rs397514253	NC_000019.10:44908530:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Feb 15, 1987	no assertion criteria provided							
NM_000041.4(APOE):c.240G>A (p.Ala80=)	APOE		Cardiovascular phenotype	VCV003231964	19	45411793	19	44908536	3231964	3385504	rs759134820	NC_000019.10:44908535:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 18, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.249C>T (p.Asp83=)	APOE		Alzheimer disease 2|Familial type 3 hyperlipoproteinemia|Alzheimer disease 4|Age related macular degeneration 1|Alzheimer disease 3|Sea-blue histiocyte syndrome|Lipoprotein glomerulopathy|Cardiovascular phenotype|not provided	VCV000760030	19	45411802	19	44908545	760030	772741	rs767980905	NC_000019.10:44908544:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.266T>C (p.Leu89Ser)	APOE	L89S, L115S	Cardiovascular phenotype	VCV003128000	19	45411819	19	44908562	3128000	3289888	rs368210726	NC_000019.10:44908561:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.268A>G (p.Lys90Glu)	APOE	K116E, K90E	not provided	VCV003340172	19	45411821	19	44908564	3340172	3499430		NC_000019.10:44908563:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.278A>G (p.Lys93Arg)	APOE	K93R, K119R	Cardiovascular phenotype	VCV003886470	19	45411831	19	44908574	3886470	3996089		NC_000019.10:44908573:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.279A>G (p.Lys93=)	APOE		Cardiovascular phenotype	VCV001796120	19	45411832	19	44908575	1796120	1852555	rs371331933	NC_000019.10:44908574:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 22, 2019	criteria provided, single submitter							
NM_000041.4(APOE):c.281C>G (p.Ser94Trp)	APOE	S120W, S94W	Cardiovascular phenotype	VCV001796422	19	45411834	19	44908577	1796422	1852857	rs776830091	NC_000019.10:44908576:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.283G>A (p.Glu95Lys)	APOE	E121K, E95K	Cardiovascular phenotype	VCV003231965	19	45411836	19	44908579	3231965	3385505	rs1969855667	NC_000019.10:44908578:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.292del (p.Glu98fs)	APOE	E124fs, E98fs	not provided	VCV000143248	19	45411844	19	44908587	143248	152980	rs527236160	NC_000019.10:44908586:GG:G	Deletion	frameshift variant	not provided		no classification provided							
NM_000041.4(APOE):c.296A>G (p.Gln99Arg)	APOE	Q99R, Q125R	Cardiovascular phenotype	VCV001798256	19	45411849	19	44908592	1798256	1856398	rs577618688	NC_000019.10:44908591:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.300G>A (p.Leu100=)	APOE		Cardiovascular phenotype	VCV003886369	19	45411853	19	44908596	3886369	92111	rs267605543	NC_000019.10:44908595:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.305C>G (p.Pro102Arg)	APOE	P102R, P128R		VCV000478905	19	45411858	19	44908601	478905	32911	rs11083750	NC_000019.10:44908600:C:G	single nucleotide variant	missense variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000041.4(APOE):c.306G>C (p.Pro102=)	APOE		Cardiovascular phenotype	VCV001799480	19	45411859	19	44908602	1799480	1855088	rs368495194	NC_000019.10:44908601:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 2, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.306G>A (p.Pro102=)	APOE		Cardiovascular phenotype	VCV001799478	19	45411859	19	44908602	1799478	1855086	rs368495194	NC_000019.10:44908601:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 9, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.310G>A (p.Ala104Thr)	APOE	A130T, A104T	Cardiovascular phenotype	VCV001727733	19	45411863	19	44908606	1727733	1794601	rs767382895	NC_000019.10:44908605:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.312G>A (p.Ala104=)	APOE		Cardiovascular phenotype	VCV001727945	19	45411865	19	44908608	1727945	1794813	rs752409518	NC_000019.10:44908607:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.321G>A (p.Thr107=)	APOE		Cardiovascular phenotype	VCV003231967	19	45411874	19	44908617	3231967	3385507	rs777571029	NC_000019.10:44908616:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.323G>A (p.Arg108Gln)	APOE	R134Q, R108Q	Cardiovascular phenotype	VCV003308503	19	45411876	19	44908619	3308503	3464178		NC_000019.10:44908618:G:A	single nucleotide variant	missense variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.327dup (p.Arg110fs)	APOE	R110fs, R136fs	not provided|Familial type 3 hyperlipoproteinemia	VCV003066201	19	45411879 - 45411880	19	44908622 - 44908623	3066201	3226214	rs761350032	NC_000019.10:44908622:A:AA	Duplication	frameshift variant	Uncertain significance	Aug 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.335C>A (p.Ser112Tyr)	APOE	S112Y, S138Y	not provided|Cardiovascular phenotype	VCV001315880	19	45411888	19	44908631	1315880	1306138	rs745552623	NC_000019.10:44908630:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.336C>G (p.Ser112=)	APOE		Cardiovascular phenotype	VCV002565617	19	45411889	19	44908632	2565617	2730573	rs11542033	NC_000019.10:44908631:C:G	single nucleotide variant	synonymous variant	Likely benign	May 11, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.339G>A (p.Lys113=)	APOE		Cardiovascular phenotype	VCV003231968	19	45411892	19	44908635	3231968	3385508	rs2513541146	NC_000019.10:44908634:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.349G>A (p.Ala117Thr)	APOE	A117T, A143T		VCV000478851	19	45411902	19	44908645	478851	32912	rs28931577	NC_000019.10:44908644:G:A	single nucleotide variant	missense variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000041.4(APOE):c.354G>T (p.Ala118=)	APOE		Cardiovascular phenotype	VCV001732582	19	45411907	19	44908650	1732582	1786269	rs768998148	NC_000019.10:44908649:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.356A>C (p.Gln119Pro)	APOE	Q119P, Q145P	not provided|Cardiovascular phenotype	VCV001710568	19	45411909	19	44908652	1710568	1708979	rs777291619	NC_000019.10:44908651:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.358G>T (p.Ala120Ser)	APOE	A120S, A146S	Cardiovascular phenotype	VCV003417851	19	45411911	19	44908654	3417851	3569110		NC_000019.10:44908653:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.362G>A (p.Arg121Gln)	APOE	R147Q, R121Q	Cardiovascular phenotype	VCV001733394	19	45411915	19	44908658	1733394	1793016	rs1969859756	NC_000019.10:44908657:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.364C>A (p.Leu122Met)	APOE	L122M, L148M	Major depressive disorder	VCV000088639	19	45411917	19	44908660	88639	94228	rs587778876	NC_000019.10:44908659:C:A	single nucleotide variant	missense variant	not provided	Jul 4, 2012	no classification provided							
NM_000041.4(APOE):c.370G>A (p.Ala124Thr)	APOE	A124T, A150T	Cardiovascular phenotype	VCV002565616	19	45411923	19	44908666	2565616	2730572	rs2513541253	NC_000019.10:44908665:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.372G>A (p.Ala124=)	APOE		Cardiovascular phenotype	VCV003886402	19	45411925	19	44908668	3886402	3999515		NC_000019.10:44908667:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.379G>C (p.Glu127Gln)	APOE	E127Q, E153Q	Cardiovascular phenotype	VCV003934778	19	45411932	19	44908675	3934778	4045317		NC_000019.10:44908674:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.381G>A (p.Glu127=)	APOE		Cardiovascular phenotype|not provided	VCV000710486	19	45411934	19	44908677	710486	728258	rs773391883	NC_000019.10:44908676:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2019	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.384C>T (p.Asp128=)	APOE		Cardiovascular phenotype	VCV002446926	19	45411937	19	44908680	2446926	2422051	rs766493265	NC_000019.10:44908679:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.387G>A (p.Val129=)	APOE		APOE-related disorder	VCV003032874	19	45411940	19	44908683	3032874	3190109	rs1056815951	NC_000019.10:44908682:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 14, 2020	no assertion criteria provided							
NM_000041.4(APOE):c.388= (p.Cys130=)	APOE			VCV000694742	19	45411941	19	44908684	694742	682795	rs429358	NC_000019.10:44908683:T:T	single nucleotide variant	no sequence alteration	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000041.3(APOE):c.[305C>G;388T>C]	APOE	C130R, C156R, P102R, P128R	APOE5 VARIANT	VCV000441269	19|19	45411941	19|19	44908684	441269	32903|32911	rs429358|rs11083750	NC_000019.10:44908683:T:C|NC_000019.10:44908600:C:G	Haplotype	missense variant	association	Nov 22, 2019	no assertion criteria provided							
NM_000041.3(APOE):c.[137T>C;388T>C]	APOE	C130R, C156R, L46P, L72P	APOE4(-)-FREIBURG|Familial hypercholesterolemia	VCV000441268	19|19	45411941	19|19	44908684	441268	32903|32909	rs429358|rs769452	NC_000019.10:44908683:T:C|NC_000019.10:44907852:T:C	Haplotype	missense variant	Pathogenic/Likely pathogenic	May 27, 2020	no assertion criteria provided							
NM_000041.3(APOE):c.[388T>C;805C>G]	APOE	C130R, C156R, R269G, R295G	Familial type 3 hyperlipoproteinemia	VCV000441267	19|19	45411941	19|19	44908684	441267	32903|38492	rs429358|rs267606661	NC_000019.10:44908683:T:C|NC_000019.10:44909100:C:G	Haplotype	missense variant	Pathogenic	May 1, 1993	no assertion criteria provided							
NM_000041.3(APOE):c.[388T>C;478C>T]	APOE	C130R, C156R, R160C, R186C	Familial type 3 hyperlipoproteinemia	VCV000440870	19|19	45411941	19|19	44908684	440870	32903|38488	rs429358|rs387906567	NC_000019.10:44908683:T:C|NC_000019.10:44908773:C:T	Haplotype	missense variant	not provided	Jun 8, 2023	no classification provided							
NM_000041.4(APOE):c.388T>C (p.Cys130Arg)	APOE	C130R, C156R	Primary degenerative dementia of the Alzheimer type, presenile onset|not specified|not provided|Lipoprotein glomerulopathy|Alzheimer disease|Alzheimer disease 4	VCV000017864	19	45411941	19	44908684	17864	32903	rs429358	NC_000019.10:44908683:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity; other; risk factor	Feb 16, 2025	criteria provided, conflicting classifications							
NM_000041.4(APOE):c.394C>G (p.Arg132Gly)	APOE	R132G, R158G	Cardiovascular phenotype	VCV003128001	19	45411947	19	44908690	3128001	3289889	rs11542041	NC_000019.10:44908689:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.394C>T (p.Arg132Cys)	APOE	R132C, R158C	not provided	VCV001317910	19	45411947	19	44908690	1317910	1309004	rs11542041	NC_000019.10:44908689:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.399G>A (p.Leu133=)	APOE		Cardiovascular phenotype	VCV003934716	19	45411952	19	44908695	3934716	4045255		NC_000019.10:44908694:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 2, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.404A>G (p.Gln135Arg)	APOE	Q135R, Q161R	Cardiovascular phenotype	VCV003417858	19	45411957	19	44908700	3417858	3569117		NC_000019.10:44908699:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.408C>T (p.Tyr136=)	APOE		Cardiovascular phenotype	VCV003417831	19	45411961	19	44908704	3417831	3569090		NC_000019.10:44908703:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 19, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.409C>G (p.Arg137Gly)	APOE	R137G, R163G	not provided	VCV002498787	19	45411962	19	44908705	2498787	2476764	rs573658040	NC_000019.10:44908704:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.415_435dup (p.Glu139_Gly145dup)	APOE		Familial type 3 hyperlipoproteinemia	VCV000017853	19	45411963 - 45411964	19	44908706 - 44908707	17853	32892	rs397514254	NC_000019.10:44908706:CGGCGAGGTGCAGGCCATGCTCGGC:CGGCGAGGTGCAGGCCATGCTCGGCGAGGTGCAGGCCATGCTCGGC	Duplication	inframe_insertion	Pathogenic	Apr 1, 2004	no assertion criteria provided							
NM_000041.4(APOE):c.414C>T (p.Gly138=)	APOE		Cardiovascular phenotype	VCV002565615	19	45411967	19	44908710	2565615	2730571	rs1267728092	NC_000019.10:44908709:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 3, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.416A>G (p.Glu139Gly)	APOE	E139G, E165G	Cardiovascular phenotype	VCV002307328	19	45411969	19	44908712	2307328	2294093	rs41382345	NC_000019.10:44908711:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.422A>G (p.Gln141Arg)	APOE	Q141R, Q167R	Familial hypercholesterolemia|Hyperlipoproteinemia|Familial type 3 hyperlipoproteinemia	VCV000917851	19	45411975	19	44908718	917851	906167	rs1969863273	NC_000019.10:44908717:A:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2020	no assertion criteria provided							
NM_000041.4(APOE):c.424G>T (p.Ala142Ser)	APOE	A168S, A142S	Cardiovascular phenotype	VCV003934808	19	45411977	19	44908720	3934808	4045347		NC_000019.10:44908719:G:T	single nucleotide variant	missense variant	Uncertain significance	May 25, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.430C>A (p.Leu144Ile)	APOE	L170I, L144I	Cardiovascular phenotype	VCV003934735	19	45411983	19	44908726	3934735	4045274		NC_000019.10:44908725:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.432C>T (p.Leu144=)	APOE		Cardiovascular phenotype	VCV001739764	19	45411985	19	44908728	1739764	1794210	rs1489359246	NC_000019.10:44908727:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 22, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.434G>A (p.Gly145Asp)	APOE	G145D, G171D	Alzheimer disease 4|Alzheimer disease 3|Alzheimer disease 2|Age related macular degeneration 1|Sea-blue histiocyte syndrome|Familial type 3 hyperlipoproteinemia|Lipoprotein glomerulopathy|Cardiovascular phenotype|Hypercholesterolemia	VCV000478904	19	45411987	19	44908730	478904	32895	rs267606664	NC_000019.10:44908729:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.441C>T (p.Ser147=)	APOE		Cardiovascular phenotype	VCV003308543	19	45411994	19	44908737	3308543	3460722		NC_000019.10:44908736:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.442A>C (p.Thr148Pro)	APOE	T174P, T148P	Cardiovascular phenotype	VCV003886459	19	45411995	19	44908738	3886459	3996078		NC_000019.10:44908737:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.444C>G (p.Thr148=)	APOE		Cardiovascular phenotype	VCV001740672	19	45411997	19	44908740	1740672	1798173	rs773479792	NC_000019.10:44908739:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.451C>A (p.Leu151Met)	APOE	L151M, L177M	Major depressive disorder	VCV000088640	19	45412004	19	44908747	88640	94229	rs587778877	NC_000019.10:44908746:C:A	single nucleotide variant	missense variant	not provided	Jan 13, 2012	no classification provided							
NM_000041.4(APOE):c.453G>C (p.Leu151=)	APOE		Cardiovascular phenotype	VCV003308507	19	45412006	19	44908749	3308507	3464182		NC_000019.10:44908748:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.455G>A (p.Arg152Gln)	APOE	R152Q, R178Q	APOE2 VARIANT	VCV000017874	19	45412008	19	44908751	17874	32913	rs28931578	NC_000019.10:44908750:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 1, 1991	no assertion criteria provided							
NM_000041.4(APOE):c.456G>T (p.Arg152=)	APOE		Cardiovascular phenotype	VCV001741558	19	45412009	19	44908752	1741558	1805002	rs1969865204	NC_000019.10:44908751:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 1, 2019	criteria provided, single submitter							
NM_000041.4(APOE):c.460C>T (p.Arg154Cys)	APOE	R180C, R154C	Familial type 3 hyperlipoproteinemia|Alzheimer disease 2	VCV003572888	19	45412013	19	44908756	3572888	3731786		NC_000019.10:44908755:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 19, 2024	criteria provided, conflicting classifications							
NM_000041.4:c.[388=;460C>A526=]	APOE	R154S, R180S	Alzheimer disease 3, protection against, due to APOE3-Christchurch	VCV000694585	19|19|19	45412013	19|19|19	44908756	694585	32889|32902|682795	rs121918393|rs429358	NC_000019.10:44908755:C:A|NC_000019.10:44908821:C:C|NC_000019.10:44908683:T:T	Haplotype	missense variant|no sequence alteration	protective	Nov 25, 2019	no assertion criteria provided							
NM_000041.4(APOE):c.460C>A (p.Arg154Ser)	APOE	R154S, R180S	Familial type 3 hyperlipoproteinemia	VCV000017850	19	45412013	19	44908756	17850	32889	rs121918393	NC_000019.10:44908755:C:A	single nucleotide variant	missense variant	Likely pathogenic	May 17, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.461G>T (p.Arg154Leu)	APOE	R154L, R180L	Abnormal circulating lipid concentration	VCV000375636	19	45412014	19	44908757	375636	362450	rs200703101	NC_000019.10:44908756:G:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 21, 2015	criteria provided, single submitter							
NM_000041.4(APOE):c.462C>T (p.Arg154=)	APOE		Cardiovascular phenotype	VCV003231969	19	45412015	19	44908758	3231969	3385509	rs753601274	NC_000019.10:44908757:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.463C>G (p.Leu155Val)	APOE	L181V, L155V	Cardiovascular phenotype	VCV003934785	19	45412016	19	44908759	3934785	4045324		NC_000019.10:44908758:C:G	single nucleotide variant	missense variant	Uncertain significance	May 23, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.465C>T (p.Leu155=)	APOE		Cardiovascular phenotype	VCV003231970	19	45412018	19	44908761	3231970	3385510	rs1356159599	NC_000019.10:44908760:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 8, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.474C>T (p.His158=)	APOE		Cardiovascular phenotype	VCV003934727	19	45412027	19	44908770	3934727	4045266		NC_000019.10:44908769:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 13, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.480_488del (p.159LRK[1])	APOE		not provided	VCV002439146	19	45412028 - 45412036	19	44908771 - 44908779	2439146	2411758	rs2513541603	NC_000019.10:44908770:CTGCGCAAGCTGCG:CTGCG	Deletion	inframe_deletion	Uncertain significance	Sep 15, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.477G>C (p.Leu159=)	APOE		Cardiovascular phenotype	VCV003417821	19	45412030	19	44908773	3417821	3569080		NC_000019.10:44908772:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 14, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.478C>T (p.Arg160Cys)	APOE	R160C, R186C	Familial type 3 hyperlipoproteinemia	VCV000487346	19	45412031	19	44908774	487346	38488	rs387906567	NC_000019.10:44908773:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 22, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.484C>A (p.Leu162Met)	APOE	L162M, L188M	Cardiovascular phenotype	VCV002624706	19	45412037	19	44908780	2624706	2793795	rs1377830202	NC_000019.10:44908779:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2025	criteria provided, single submitter							
NM_000041.3(APOE):c.[487C>T;91G>A]	APOE	R163C, R189C, E31K, E57K	Familial type 3 hyperlipoproteinemia	VCV000441264	19|19	45412040	19|19	44908783	441264	32890|32899	rs769455|rs201672011	NC_000019.10:44908782:C:T|NC_000019.10:44907806:G:A	Haplotype	missense variant	Pathogenic	Nov 1, 1992	no assertion criteria provided							
NM_000041.4(APOE):c.487C>T (p.Arg163Cys)	APOE	R163C, R189C	Cardiovascular phenotype|not specified|not provided|Alzheimer disease 2	VCV000017851	19	45412040	19	44908783	17851	32890	rs769455	NC_000019.10:44908782:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 17, 2023	criteria provided, conflicting classifications							
NM_000041.4(APOE):c.488G>T (p.Arg163Leu)	APOE	R163L, R189L	Lipoprotein glomerulopathy	VCV001687222	19	45412041	19	44908784	1687222	1679515	rs121918397	NC_000019.10:44908783:G:T	single nucleotide variant	missense variant	Uncertain significance	May 22, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.488G>C (p.Arg163Pro)	APOE	R163P, R189P	Lipoprotein glomerulopathy	VCV000017879	19	45412041	19	44908784	17879	32918	rs121918397	NC_000019.10:44908783:G:C	single nucleotide variant	missense variant	Pathogenic	Oct 6, 2000	no assertion criteria provided							
NM_000041.4(APOE):c.488G>A (p.Arg163His)	APOE	R163H, R189H	Lipoprotein glomerulopathy	VCV000017865	19	45412041	19	44908784	17865	32904	rs121918397	NC_000019.10:44908783:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 22, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.489T>G (p.Arg163=)	APOE		Cardiovascular phenotype	VCV001743923	19	45412042	19	44908785	1743923	1802267	rs1599953670	NC_000019.10:44908784:T:G	single nucleotide variant	synonymous variant	Likely benign	Oct 12, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.490A>C (p.Lys164Gln)	APOE	K164Q, K190Q	Hyperlipoproteinemia, type III, due to APOE2	VCV000017858	19	45412043	19	44908786	17858	32897	rs121918394	NC_000019.10:44908785:A:C	single nucleotide variant	missense variant	Pathogenic	Jan 1, 1990	no assertion criteria provided							
NM_000041.4(APOE):c.490A>G (p.Lys164Glu)	APOE	K164E, K190E	Familial type 3 hyperlipoproteinemia	VCV000017857	19	45412043	19	44908786	17857	32896	rs121918394	NC_000019.10:44908785:A:G	single nucleotide variant	missense variant	Pathogenic	Aug 1, 1995	no assertion criteria provided							
NM_000041.4(APOE):c.494G>C (p.Arg165Pro)	APOE	R165P, R191P	Lipoprotein glomerulopathy	VCV001077013	19	45412047	19	44908790	1077013	1065682	rs1332591068	NC_000019.10:44908789:G:C	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_000041.4(APOE):c.495G>T (p.Arg165=)	APOE		APOE-related disorder	VCV003055012	19	45412048	19	44908791	3055012	3206169	rs1347476726	NC_000019.10:44908790:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2020	no assertion criteria provided							
NM_000041.4(APOE):c.497TCC[1] (p.Leu167del)	APOE	L167del, L193del	APOE-related disorder|Cardiovascular phenotype|Familial hypercholesterolemia|not provided	VCV000126456	19	45412049 - 45412051	19	44908792 - 44908794	126456	131982	rs515726148	NC_000019.10:44908791:CTCCTCC:CTCC	Microsatellite	inframe_deletion	Pathogenic	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.503G>A (p.Arg168His)	APOE	R168H, R194H	not provided	VCV003380625	19	45412056	19	44908799	3380625	3539798		NC_000019.10:44908798:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.508G>C (p.Ala170Pro)	APOE	A170P, A196P		VCV000478850	19	45412061	19	44908804	478850	38495	rs267606662	NC_000019.10:44908803:G:C	single nucleotide variant	missense variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000041.3(APOE):c.[349G>A;508G>C]	APOE	A170P, A196P, A117T, A143T	APOE3 VARIANT	VCV000441270	19|19	45412061	19|19	44908804	441270	38495|32912	rs267606662|rs28931577	NC_000019.10:44908803:G:C|NC_000019.10:44908644:G:A	Haplotype	missense variant	Pathogenic	May 25, 1984	no assertion criteria provided							
NM_000041.4(APOE):c.513T>G (p.Asp171Glu)	APOE	D171E, D197E	Alzheimer disease 2	VCV003779932	19	45412066	19	44908809	3779932	3895901		NC_000019.10:44908808:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.513T>C (p.Asp171=)	APOE		Cardiovascular phenotype	VCV003308535	19	45412066	19	44908809	3308535	3460714		NC_000019.10:44908808:T:C	single nucleotide variant	synonymous variant	Likely benign	May 11, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.526= (p.Arg176=)	APOE			VCV000694741	19	45412079	19	44908822	694741	32902		NC_000019.10:44908821:C:C	Variation	no sequence alteration	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000041.3(APOE):c.[526C>T;725G>A]	APOE	R176C, R202C, R268Q	Familial type 3 hyperlipoproteinemia	VCV000441265	19|19	45412079	19|19	44908822	441265	32887|38490	rs7412|rs267606663	NC_000019.10:44908821:C:T|NC_000019.10:44909020:G:A	Haplotype	missense variant	Pathogenic	Feb 21, 2017	no assertion criteria provided							
NM_000041.3(APOE):c.[434G>A;526C>T]	APOE	R176C, R202C, G145D, G171D	Hyperlipoproteinemia due to APOE1	VCV000441262	19|19	45412079	19|19	44908822	441262	32887|32895	rs7412|rs267606664	NC_000019.10:44908821:C:T|NC_000019.10:44908729:G:A	Haplotype	missense variant	Pathogenic	Apr 1, 1984	no assertion criteria provided							
NM_000041.4(APOE):c.[388=;526=]	APOE		APOE3 ISOFORM	VCV000017863	19|19	45412079	19|19	44908822	17863	32902|682795	rs429358	NC_000019.10:44908821:C:C|NC_000019.10:44908683:T:T	Haplotype	no sequence alteration	Pathogenic	Sep 10, 1981	no assertion criteria provided							
NM_000041.2(APOE):c.526C>T (p.Arg176Cys)	APOE	R176C, R202C	atorvastatin response - Efficacy	VCV000017848	19	45412079	19	44908822	17848	32887	rs7412	NC_000019.10:44908821:C:T	single nucleotide variant	missense variant	drug response	Mar 24, 2021	reviewed by expert panel							
NM_000041.4(APOE):c.537G>A (p.Val179=)	APOE		Cardiovascular phenotype	VCV001747154	19	45412090	19	44908833	1747154	1802905	rs1465409896	NC_000019.10:44908832:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 17, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.541C>A (p.Gln181Lys)	APOE	Q181K, Q207K	Alzheimer disease 2	VCV003779933	19	45412094	19	44908837	3779933	3895902		NC_000019.10:44908836:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.541C>G (p.Gln181Glu)	APOE	Q181E, Q207E	not provided	VCV002499313	19	45412094	19	44908837	2499313	2477289	rs1434405741	NC_000019.10:44908836:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.542A>T (p.Gln181Leu)	APOE	Q181L, Q207L	Cardiovascular phenotype	VCV001747488	19	45412095	19	44908838	1747488	1799786	rs2513541830	NC_000019.10:44908837:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.543G>T (p.Gln181His)	APOE	Q181H, Q207H	Cardiovascular phenotype	VCV003417748	19	45412096	19	44908839	3417748	3569007		NC_000019.10:44908838:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.544G>C (p.Ala182Pro)	APOE	A182P, A208P	Cardiovascular phenotype	VCV002562132	19	45412097	19	44908840	2562132	2720985	rs796443813	NC_000019.10:44908839:G:C	single nucleotide variant	missense variant	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.546C>T (p.Ala182=)	APOE		Cardiovascular phenotype	VCV001747722	19	45412099	19	44908842	1747722	1800020	rs1368598158	NC_000019.10:44908841:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 23, 2019	criteria provided, single submitter							
NM_000041.4(APOE):c.548G>C (p.Gly183Ala)	APOE	G183A, G209A	Familial type 3 hyperlipoproteinemia	VCV001341575	19	45412101	19	44908844	1341575	1332824	rs2122137937	NC_000019.10:44908843:G:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 15, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.552C>T (p.Ala184=)	APOE		Cardiovascular phenotype	VCV001748127	19	45412105	19	44908848	1748127	1810316	rs1599953921	NC_000019.10:44908847:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.555C>T (p.Arg185=)	APOE		Cardiovascular phenotype	VCV001748286	19	45412108	19	44908851	1748286	1806534	rs781722239	NC_000019.10:44908850:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 20, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.563C>G (p.Ala188Gly)	APOE	A214G, A188G	Cardiovascular phenotype	VCV003417918	19	45412116	19	44908859	3417918	3569177		NC_000019.10:44908858:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.570C>G (p.Arg190=)	APOE		Cardiovascular phenotype	VCV003231973	19	45412123	19	44908866	3231973	3385513	rs1420542504	NC_000019.10:44908865:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.572G>A (p.Gly191Asp)	APOE	G191D, G217D	not provided	VCV004077225	19	45412125	19	44908868	4077225	4189907		NC_000019.10:44908867:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.574C>G (p.Leu192Val)	APOE	L192V, L218V	Alzheimer disease 2	VCV003779934	19	45412127	19	44908870	3779934	3895903		NC_000019.10:44908869:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.583A>T (p.Ile195Phe)	APOE	I195F, I221F	Cardiovascular phenotype	VCV002562131	19	45412136	19	44908879	2562131	2720984	rs1380773651	NC_000019.10:44908878:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.588C>A (p.Arg196=)	APOE		Cardiovascular phenotype	VCV002565619	19	45412141	19	44908884	2565619	2730575	rs992491839	NC_000019.10:44908883:C:A	single nucleotide variant	synonymous variant	Likely benign	May 28, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.588C>T (p.Arg196=)	APOE		Cardiovascular phenotype	VCV001750302	19	45412141	19	44908884	1750302	1807280	rs992491839	NC_000019.10:44908883:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 3, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.591G>A (p.Glu197=)	APOE		Cardiovascular phenotype	VCV001750497	19	45412144	19	44908887	1750497	1803647	rs928986800	NC_000019.10:44908886:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.598G>A (p.Gly200Arg)	APOE	G226R, G200R	Cardiovascular phenotype	VCV003934800	19	45412151	19	44908894	3934800	4045339		NC_000019.10:44908893:G:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.598G>C (p.Gly200Arg)	APOE	G200R, G226R	Cardiovascular phenotype	VCV001750896	19	45412151	19	44908894	1750896	1800625	rs1164213063	NC_000019.10:44908893:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.605T>C (p.Leu202Pro)	APOE	L228P, L202P	Cardiovascular phenotype	VCV003886422	19	45412158	19	44908901	3886422	3999535		NC_000019.10:44908900:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.615G>A (p.Gln205=)	APOE		Cardiovascular phenotype	VCV001751939	19	45412168	19	44908911	1751939	1807620	rs2513542057	NC_000019.10:44908910:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 11, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.616G>A (p.Gly206Ser)	APOE	G232S, G206S	Cardiovascular phenotype	VCV003886431	19	45412169	19	44908912	3886431	3996050		NC_000019.10:44908911:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.621C>T (p.Arg207=)	APOE		Cardiovascular phenotype	VCV002586036	19	45412174	19	44908917	2586036	2753596	rs1296647170	NC_000019.10:44908916:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 18, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.621C>G (p.Arg207=)	APOE		Cardiovascular phenotype	VCV002562134	19	45412174	19	44908917	2562134	2720987	rs1296647170	NC_000019.10:44908916:C:G	single nucleotide variant	synonymous variant	Likely benign	May 27, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.621C>A (p.Arg207=)	APOE		Cardiovascular phenotype	VCV001752261	19	45412174	19	44908917	1752261	1804116	rs1296647170	NC_000019.10:44908916:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.623T>G (p.Val208Gly)	APOE	V208G, V234G	Cardiovascular phenotype	VCV001752385	19	45412176	19	44908919	1752385	1804240	rs2513542082	NC_000019.10:44908918:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.625C>T (p.Arg209Trp)	APOE	R235W, R209W	Cardiovascular phenotype	VCV002586037	19	45412178	19	44908921	2586037	2753597	rs1459595735	NC_000019.10:44908920:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.626G>A (p.Arg209Gln)	APOE	R209Q, R235Q	Cardiovascular phenotype	VCV003886481	19	45412179	19	44908922	3886481	3996100		NC_000019.10:44908921:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.627G>A (p.Arg209=)	APOE		Cardiovascular phenotype	VCV001752588	19	45412180	19	44908923	1752588	1801022	rs774452222	NC_000019.10:44908922:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 10, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.631G>A (p.Ala211Thr)	APOE	A237T, A211T	Cardiovascular phenotype	VCV003417899	19	45412184	19	44908927	3417899	3569158		NC_000019.10:44908926:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.638T>G (p.Val213Gly)	APOE	V239G, V213G	Cardiovascular phenotype	VCV001753235	19	45412191	19	44908934	1753235	1811559	rs1227709957	NC_000019.10:44908933:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.639G>T (p.Val213=)	APOE		Cardiovascular phenotype|not provided	VCV000718465	19	45412192	19	44908935	718465	728259	rs1313313298	NC_000019.10:44908934:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.640G>A (p.Gly214Ser)	APOE	G214S, G240S	Cardiovascular phenotype	VCV001753374	19	45412193	19	44908936	1753374	1811698	rs759721023	NC_000019.10:44908935:G:A	single nucleotide variant	missense variant	Uncertain significance	May 1, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.642C>T (p.Gly214=)	APOE		Cardiovascular phenotype	VCV003231975	19	45412195	19	44908938	3231975	3385515	rs1969875907	NC_000019.10:44908937:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 18, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.651C>T (p.Ala217=)	APOE		Age related macular degeneration 1|Lipoprotein glomerulopathy|Alzheimer disease 2|Sea-blue histiocyte syndrome|Familial type 3 hyperlipoproteinemia|Alzheimer disease 3|Alzheimer disease 4|not provided|Cardiovascular phenotype	VCV000779286	19	45412204	19	44908947	779286	716517	rs72654468	NC_000019.10:44908946:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.652G>T (p.Gly218Cys)	APOE	G244C, G218C	Cardiovascular phenotype	VCV003417728	19	45412205	19	44908948	3417728	3568987		NC_000019.10:44908947:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.655C>G (p.Gln219Glu)	APOE	Q245E, Q219E	Cardiovascular phenotype	VCV002565618	19	45412208	19	44908951	2565618	2730574	rs941248161	NC_000019.10:44908950:C:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.670C>T (p.Arg224Trp)	APOE	R224W, R250W	Cardiovascular phenotype	VCV002338186	19	45412223	19	44908966	2338186	2329229	rs2513542199	NC_000019.10:44908965:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.672G>T (p.Arg224=)	APOE		Cardiovascular phenotype	VCV001755132	19	45412225	19	44908968	1755132	1822221	rs2513542211	NC_000019.10:44908967:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.683G>A (p.Trp228Ter)	APOE	W228*, W254*	not provided	VCV000017862	19	45412236	19	44908979	17862	32901	rs121918396	NC_000019.10:44908978:G:A	single nucleotide variant	nonsense	Likely pathogenic	Aug 4, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.688G>A (p.Glu230Lys)	APOE	E230K, E256K	not provided|Alzheimer disease 3|Alzheimer disease 2|Alzheimer disease 4|Sea-blue histiocyte syndrome|Age related macular degeneration 1|Lipoprotein glomerulopathy|Familial type 3 hyperlipoproteinemia|Lipoprotein glomerulopathy	VCV001315806	19	45412241	19	44908984	1315806	1306064	rs567353589	NC_000019.10:44908983:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.691C>T (p.Arg231Trp)	APOE	R231W, R257W	Cardiovascular phenotype	VCV003417910	19	45412244	19	44908987	3417910	3569169		NC_000019.10:44908986:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.691C>A (p.Arg231=)	APOE		Cardiovascular phenotype	VCV001756154	19	45412244	19	44908987	1756154	1812332	rs1381171305	NC_000019.10:44908986:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.692G>T (p.Arg231Leu)	APOE	R231L, R257L	not provided	VCV002499380	19	45412245	19	44908988	2499380	2477356	rs1237339516	NC_000019.10:44908987:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.699C>T (p.Arg233=)	APOE		Cardiovascular phenotype	VCV001756513	19	45412252	19	44908995	1756513	1822326	rs1354007902	NC_000019.10:44908994:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.700G>A (p.Ala234Thr)	APOE	A260T, A234T	Cardiovascular phenotype	VCV003308514	19	45412253	19	44908996	3308514	3464189		NC_000019.10:44908995:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.702G>A (p.Ala234=)	APOE		Cardiovascular phenotype	VCV001756777	19	45412255	19	44908998	1756777	1822588	rs1441106443	NC_000019.10:44908997:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.705G>A (p.Arg235=)	APOE		Cardiovascular phenotype	VCV003886411	19	45412258	19	44909001	3886411	3999524		NC_000019.10:44909000:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.709G>A (p.Glu237Lys)	APOE	E263K, E237K	Cardiovascular phenotype	VCV001757142	19	45412262	19	44909005	1757142	1819147	rs1335550286	NC_000019.10:44909004:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.714G>C (p.Glu238Asp)	APOE	E264D, E238D	Cardiovascular phenotype	VCV002586039	19	45412267	19	44909010	2586039	2753599	rs892532644	NC_000019.10:44909009:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.714G>T (p.Glu238Asp)	APOE	E238D, E264D	Cardiovascular phenotype	VCV002219434	19	45412267	19	44909010	2219434	2206754	rs892532644	NC_000019.10:44909009:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.718G>A (p.Gly240Ser)	APOE	G240S, G266S	Cardiovascular phenotype	VCV003934706	19	45412271	19	44909014	3934706	4045245		NC_000019.10:44909013:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.719G>A (p.Gly240Asp)	APOE	G266D, G240D	Cardiovascular phenotype	VCV002586038	19	45412272	19	44909015	2586038	2753598	rs1391215146	NC_000019.10:44909014:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_000041.2(APOE):c.725G>A (p.Arg242Gln)	APOE	R268Q		VCV000478870	19	45412278	19	44909021	478870	38490	rs267606663	NC_000019.10:44909020:G:A	single nucleotide variant	missense variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000041.4(APOE):c.726G>A (p.Arg242=)	APOE		Cardiovascular phenotype	VCV003417793	19	45412279	19	44909022	3417793	3569052		NC_000019.10:44909021:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 28, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.727A>T (p.Thr243Ser)	APOE	T243S, T269S	Cardiovascular phenotype	VCV003128002	19	45412280	19	44909023	3128002	3289890	rs1969880357	NC_000019.10:44909022:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.729C>T (p.Thr243=)	APOE		Cardiovascular phenotype	VCV003886449	19	45412282	19	44909025	3886449	3996068		NC_000019.10:44909024:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 15, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.733G>T (p.Asp245Tyr)	APOE	D271Y, D245Y	Cardiovascular phenotype	VCV003308526	19	45412286	19	44909029	3308526	3460705		NC_000019.10:44909028:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.736C>T (p.Arg246Cys)	APOE	R246C, R272C	APOE2-DUNEDIN|HYPERLIPOPROTEINEMIA, TYPE IV/V, DUE TO APOE2-DUNEDIN	VCV000017859	19	45412289	19	44909032	17859	32898	rs121918395	NC_000019.10:44909031:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 1, 1991	no assertion criteria provided							
NM_000041.4(APOE):c.737G>A (p.Arg246His)	APOE	R272H, R246H	Cardiovascular phenotype	VCV003934668	19	45412290	19	44909033	3934668	4045207		NC_000019.10:44909032:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.737G>C (p.Arg246Pro)	APOE	R246P, R272P	not provided|Cardiovascular phenotype	VCV002572764	19	45412290	19	44909033	2572764	2737706	rs1330553726	NC_000019.10:44909032:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.739C>G (p.Leu247Val)	APOE	L273V, L247V	Cardiovascular phenotype	VCV001758697	19	45412292	19	44909035	1758697	1819408	rs2513542435	NC_000019.10:44909034:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.744C>G (p.Asp248Glu)	APOE	D274E, D248E	Cardiovascular phenotype	VCV003886391	19	45412297	19	44909040	3886391	3999504		NC_000019.10:44909039:C:G	single nucleotide variant	missense variant	Likely benign	Dec 21, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.747G>A (p.Glu249=)	APOE		Cardiovascular phenotype|not provided	VCV000729588	19	45412300	19	44909043	729588	741977	rs771354248	NC_000019.10:44909042:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.761T>A (p.Val254Glu)	APOE	V254E, V280E	not provided	VCV000478872	19	45412314	19	44909057	478872	38491	rs199768005	NC_000019.10:44909056:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.764C>T (p.Ala255Val)	APOE	A255V, A281V	Cardiovascular phenotype	VCV003417889	19	45412317	19	44909060	3417889	3569148		NC_000019.10:44909059:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.765G>A (p.Ala255=)	APOE		not provided	VCV000741936	19	45412318	19	44909061	741936	757106	rs752327439	NC_000019.10:44909060:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 24, 2018	criteria provided, single submitter							
NM_000041.4(APOE):c.767A>T (p.Glu256Val)	APOE	E256V, E282V	Cardiovascular phenotype	VCV001760098	19	45412320	19	44909063	1760098	1823334	rs1197351070	NC_000019.10:44909062:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.773G>A (p.Arg258His)	APOE	R258H, R284H	Cardiovascular phenotype	VCV001760393	19	45412326	19	44909069	1760393	1819821	rs756564996	NC_000019.10:44909068:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.774C>G (p.Arg258=)	APOE		Cardiovascular phenotype	VCV003417813	19	45412327	19	44909070	3417813	3569072		NC_000019.10:44909069:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.784G>A (p.Glu262Lys)	APOE	E262K, E288K	Cardiovascular phenotype|Alzheimer disease 2	VCV000478832	19	45412337	19	44909080	478832	32893	rs140808909	NC_000019.10:44909079:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 25, 2024	criteria provided, conflicting classifications							
NM_000041.3(APOE):c.[784G>A;787G>A]	APOE	E262K, E288K, E263K, E289K	HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7	VCV000441263	19|19	45412337	19|19	44909080	441263	32893|38487	rs140808909|rs190853081	NC_000019.10:44909079:G:A|NC_000019.10:44909082:G:A	Haplotype	missense variant	Pathogenic	Aug 1, 1995	no assertion criteria provided							
NM_000041.4(APOE):c.786G>A (p.Glu262=)	APOE		Cardiovascular phenotype	VCV001209955	19	45412339	19	44909082	1209955	1200084	rs569017773	NC_000019.10:44909081:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.787G>A (p.Glu263Lys)	APOE	E263K, E289K	Cardiovascular phenotype|Alzheimer disease 2	VCV000478838	19	45412340	19	44909083	478838	38487	rs190853081	NC_000019.10:44909082:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 25, 2024	criteria provided, conflicting classifications							
NM_000041.4(APOE):c.789G>A (p.Glu263=)	APOE		Cardiovascular phenotype	VCV001761097	19	45412342	19	44909085	1761097	1816712	rs1427053863	NC_000019.10:44909084:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 22, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.804A>C (p.Ile268=)	APOE		Cardiovascular phenotype	VCV003308522	19	45412357	19	44909100	3308522	3460701		NC_000019.10:44909099:A:C	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.805C>G (p.Arg269Gly)	APOE	R269G, R295G	Alzheimer disease 4|Alzheimer disease 3|Alzheimer disease 2|Age related macular degeneration 1|Sea-blue histiocyte syndrome|Familial type 3 hyperlipoproteinemia|Lipoprotein glomerulopathy|not provided|Cardiovascular phenotype|Alzheimer disease 2|Familial type 3 hyperlipoproteinemia	VCV000478884	19	45412358	19	44909101	478884	38492	rs267606661	NC_000019.10:44909100:C:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.808C>T (p.Leu270=)	APOE		not provided|Cardiovascular phenotype	VCV000739514	19	45412361	19	44909104	739514	757107	rs992440908	NC_000019.10:44909103:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2019	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.810G>A (p.Leu270=)	APOE		Cardiovascular phenotype	VCV001762036	19	45412363	19	44909106	1762036	1820172	rs747184737	NC_000019.10:44909105:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 13, 2021	criteria provided, single submitter							
NM_000041.4(APOE):c.818A>G (p.Glu273Gly)	APOE	E273G, E299G	Cardiovascular phenotype	VCV002446927	19	45412371	19	44909114	2446927	2422052	rs951182634	NC_000019.10:44909113:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.832C>T (p.Arg278Cys)	APOE	R278C, R304C	Cardiovascular phenotype	VCV001762954	19	45412385	19	44909128	1762954	1814047	rs762845923	NC_000019.10:44909127:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.833G>T (p.Arg278Leu)	APOE	R278L, R304L	Cardiovascular phenotype	VCV002594997	19	45412386	19	44909129	2594997	2762534	rs767339630	NC_000019.10:44909128:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2023	criteria provided, single submitter							
NM_000041.4(APOE):c.849C>T (p.Phe283=)	APOE		Cardiovascular phenotype	VCV001763601	19	45412402	19	44909145	1763601	1824325	rs954301448	NC_000019.10:44909144:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.854C>A (p.Pro285His)	APOE	P285H, P311H	Cardiovascular phenotype	VCV003308517	19	45412407	19	44909150	3308517	3464192		NC_000019.10:44909149:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.855C>G (p.Pro285=)	APOE		Cardiovascular phenotype	VCV003934752	19	45412408	19	44909151	3934752	4045291		NC_000019.10:44909150:C:G	single nucleotide variant	synonymous variant	Likely benign	May 24, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.856C>T (p.Leu286=)	APOE		Cardiovascular phenotype	VCV001763883	19	45412409	19	44909152	1763883	1820749	rs750138933	NC_000019.10:44909151:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.866A>C (p.Asp289Ala)	APOE	D289A, D315A	not provided	VCV001706316	19	45412419	19	44909162	1706316	1704630	rs1568618190	NC_000019.10:44909161:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2022	criteria provided, single submitter							
NM_000041.4(APOE):c.873G>C (p.Gln291His)	APOE	Q291H, Q317H	Familial hypercholesterolemia	VCV003340082	19	45412426	19	44909169	3340082	3499343		NC_000019.10:44909168:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2023	no assertion criteria provided							
NM_000041.4(APOE):c.875G>A (p.Arg292His)	APOE	R292H, R318H	APOE4 VARIANT	VCV000017875	19	45412428	19	44909171	17875	32914	rs121918398	NC_000019.10:44909170:G:A	single nucleotide variant	missense variant	Pathogenic	May 1, 1993	no assertion criteria provided							
NM_000041.4(APOE):c.882G>T (p.Trp294Cys)	APOE	W294C, W320C	Cardiovascular phenotype|not provided|Familial type 3 hyperlipoproteinemia	VCV001764810	19	45412435	19	44909178	1764810	1814631	rs557715042	NC_000019.10:44909177:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.886G>T (p.Gly296Trp)	APOE	G296W, G322W	APOE-related disorder	VCV003352089	19	45412439	19	44909182	3352089	3511313		NC_000019.10:44909181:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2024	no assertion criteria provided							
NM_000041.4(APOE):c.895G>C (p.Glu299Gln)	APOE	E325Q, E299Q	Cardiovascular phenotype	VCV001765256	19	45412448	19	44909191	1765256	1824750	rs1367811482	NC_000019.10:44909190:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.901G>T (p.Val301Leu)	APOE	V327L, V301L	Cardiovascular phenotype	VCV003934698	19	45412454	19	44909197	3934698	4045237		NC_000019.10:44909196:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.901G>A (p.Val301Met)	APOE	V327M, V301M	Cardiovascular phenotype	VCV003886441	19	45412454	19	44909197	3886441	3996060		NC_000019.10:44909196:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.912C>A (p.Ala304=)	APOE		Cardiovascular phenotype	VCV003934757	19	45412465	19	44909208	3934757	4045296		NC_000019.10:44909207:C:A	single nucleotide variant	synonymous variant	Likely benign	May 24, 2025	criteria provided, single submitter							
NM_000041.4(APOE):c.912C>T (p.Ala304=)	APOE		Cardiovascular phenotype	VCV001765901	19	45412465	19	44909208	1765901	1817851	rs772936346	NC_000019.10:44909207:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 13, 2020	criteria provided, single submitter							
NM_000041.4(APOE):c.913G>T (p.Val305Leu)	APOE	V305L, V331L	Cardiovascular phenotype	VCV003417786	19	45412466	19	44909209	3417786	3569045		NC_000019.10:44909208:G:T	single nucleotide variant	missense variant	Likely benign	Jul 3, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.924C>T (p.Ser308=)	APOE		Cardiovascular phenotype	VCV001766316	19	45412477	19	44909220	1766316	1814894	rs1245915178	NC_000019.10:44909219:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2019	criteria provided, single submitter							
NM_000041.4(APOE):c.927C>G (p.Ala309=)	APOE		Cardiovascular phenotype	VCV001766409	19	45412480	19	44909223	1766409	1814987	rs774354369	NC_000019.10:44909222:C:G	single nucleotide variant	synonymous variant	Likely benign	May 17, 2019	criteria provided, single submitter							
NM_000041.4(APOE):c.930C>G (p.Ala310=)	APOE		Cardiovascular phenotype	VCV003308529	19	45412483	19	44909226	3308529	3460708		NC_000019.10:44909225:C:G	single nucleotide variant	synonymous variant	Likely benign	May 5, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.932C>T (p.Pro311Leu)	APOE	P337L, P311L	Cardiovascular phenotype	VCV003308501	19	45412485	19	44909228	3308501	3464176		NC_000019.10:44909227:C:T	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.940A>C (p.Ser314Arg)	APOE	S314R, S340R	APOE4(+)	VCV000017876	19	45412493	19	44909236	17876	32915	rs28931579	NC_000019.10:44909235:A:C	single nucleotide variant	missense variant	Pathogenic	May 1, 1993	no assertion criteria provided							
NM_000041.4(APOE):c.942C>T (p.Ser314=)	APOE		not provided|Cardiovascular phenotype	VCV000726778	19	45412495	19	44909238	726778	741978	rs1051068315	NC_000019.10:44909237:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000041.4(APOE):c.945C>T (p.Asp315=)	APOE		Cardiovascular phenotype	VCV003417868	19	45412498	19	44909241	3417868	3569127		NC_000019.10:44909240:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2024	criteria provided, single submitter							
NM_000041.4(APOE):c.*5C>T	APOE		APOE-related disorder	VCV003350760	19	45412512	19	44909255	3350760	3509986		NC_000019.10:44909254:C:T	single nucleotide variant	3 prime UTR variant	Likely benign	Aug 28, 2024	no assertion criteria provided							
NC_000019.10:g.44909484C>G	APOE		not provided	VCV001197019	19	45412741	19	44909484	1197019	1188789	rs117656888	NC_000019.10:44909483:C:G	single nucleotide variant		Likely benign	Apr 14, 2019	criteria provided, single submitter							
NC_000019.10:g.44909535del	APOE		not provided	VCV001287640	19	45412779	19	44909522	1287640	1277472	rs747519137	NC_000019.10:44909521:TTTTTTTTTTTTTT:TTTTTTTTTTTTT	Deletion		Benign	Aug 7, 2019	criteria provided, single submitter							
NC_000019.10:g.44911194T>C	APOE		Warfarin response	VCV000619953	19	45414451	19	44911194	619953	611350	rs439401	NC_000019.10:44911193:T:C	single nucleotide variant		drug response	Aug 31, 2010	no assertion criteria provided							
GRCh37/hg19 19q13.31-13.32(chr19:45074342-46133841)	MARK4|NECTIN2|NKPD1|OPA3|POLR1G|PPM1N|PPP1R13L|PPP1R37|PVR|RELB|APOC1|APOC2|APOC4|APOE|BCAM|BCL3|BLOC1S3|CBLC|CEACAM16|CEACAM19|CKM|CLASRP|CLPTM1|EML2|ERCC1|ERCC2|EXOC3L2|FOSB|GEMIN7|GPR4|IGSF23|KLC3|RTN2|TOMM40|TRAPPC6A|TRU-TCA1-1|VASP|ZNF296		not specified	VCV001526667	19	45074342 - 46133841			1526667	1518156			copy number gain		Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
GRCh37/hg19 19q13.31-13.42(chr19:44738088-53621561)x3	CEACAM19|CEACAM20|ERVV-2|IRF3|LIN7B|LMTK3|PLEKHA4|SNRPD2|SPACA4|SPHK2|ZNF28|ZSWIM9|ZNF480|ZNF534|ZNF541|ZNF528|ZNF320|ZNF285|ZNF296|ZNF350|ZNF415|SYMPK|TBC1D17|TEAD2|TMEM143|TMEM160|TOMM40|TPRX1|SYNGR4|SYT3|ZNF432|ZNF468|ZNF473|SPIB|STRN4|RASIP1|RCN3|RELB|RPL13A|RPS11|PPP1R37|RPL18|SULT2A1|SULT2B1|PNKP|PNMA8A|PNMA8B|PVR|MIRLET7E|MYBPC2|MYH14|MYPOP|NANOS2|NAPA|MAMSTR|MARK4|MED25|QPCTL|LRRC4B|MEIS3|KCNJ14|KDELR1|KLC3|KLK1|KASH5|JOSD2|MIR125A|MIR150|MIR99B|IZUMO1|IZUMO2|KCNA7|FPR1|FPR2|FPR3|GIPR|GNG8|FLT3LG|FOSB|FOXA3|KCNC3|CGB7|CGB8|CKM|CLASRP|CPT1C|CLDND2|CRX|CLEC11A|CLPTM1|CGB3|CGB5|FKRP|ACP4|APOC1|ADM5|AKT1S1|ALDH16A1|AP2A1|AP2S1|BAX|CGB1|CGB2|APOC2|APOC4|APOE|ARHGAP35|ASPDH|ATF5|BBC3|BCAM|BCAT2|BCL2L12|BCL3|BICRA|BLOC1S3|BSPH1|C19orf73|C19orf81|C5AR1|C5AR2|CA11|CABP5|CALM3|CARD8|CBLC|CCDC61|CCDC8|CCDC9|CD33|CD37|CEACAM16|CEACAM18|CTU1|CYTH2|DACT3|DBP|DHDH|DHX34|DKKL1|DMPK|DMWD|EHD2|ELSPBP1|EMC10|EML2|EMP3|ERCC1|ERCC2|ERVV-1|ETFB|EXOC3L2|FAM83E|FBXO46|FCGRT|FGF21|FTL|FUT1|FUT2|FUZ|GARIN5A|GEMIN7|GPR32|GPR4|GRIN2D|GRWD1|GYS1|HAS1|HIF3A|HRC|HSD17B14|IGFL1|IGFL2|IGFL3|IGFL4|IGLON5|IGSF23|IL4I1|INAFM1|IRF2BP1|KLK10|KLK11|KLK12|KLK13|KLK14|KLK15|KLK2|KLK3|KLK4|KLK5|KLK6|KLK7|KLK8|KLK9|KPTN|LHB|LIG1|LIM2|NAPSA|NECTIN2|NKG7|NKPD1|NOP53|NOSIP|NOVA2|NPAS1|NR1H2|NTF4|NTN5|NUCB1|NUP62|ODAD1|OPA3|PGLYRP1|PIH1D1|PLA2G4C|POLD1|POLR1G|PPFIA3|PPM1N|PPP1R13L|PPP1R15A|PPP2R1A|PPP5C|PPP5D1|PRKD2|PRMT1|PRR12|PRRG2|PTGIR|PTH2|PTOV1|PTOV1-AS2|RRAS|RSPH6A|RTN2|RUVBL2|SAE1|SCAF1|SELENOW|SHANK1|SIGLEC10|SIGLEC11|SIGLEC12|SIGLEC14|SIGLEC5|SIGLEC6|SIGLEC7|SIGLEC8|SIGLEC9|SIGLECL1|SIX5|SLC17A7|SLC1A5|SLC6A16|SLC8A2|SNRNP70|TRAPPC6A|TRPM4|TRU-TCA1-1|TSKS|TULP2|VASP|VRK3|VSIG10L|ZC3H4|ZNF112|ZNF114|ZNF160|ZNF175|ZNF180|ZNF227|ZNF229|ZNF233|ZNF235|ZNF577|ZNF578|ZNF600|ZNF610|ZNF611|ZNF613|ZNF614|ZNF615|ZNF616|ZNF649|ZNF701|ZNF766|ZNF808|ZNF816|ZNF816-ZNF321P|ZNF83|ZNF836|ZNF841|ZNF880|ZNF888		not provided	VCV000816084	19	44738088 - 53621561			816084	804292			copy number gain		Pathogenic	Jul 6, 2018	no assertion criteria provided							
GRCh37/hg19 19q11-13.33(chr19:28271106-49213832)x3	ACP7|ACTMAP|ACTN4|AKT2|ALKBH6|ANKRD27|AP2S1|APLP1|APOC1|APOC2|APOC4|APOE|ARHGAP33|ARHGAP35|ARHGEF1|ATP1A3|ATP4A|AXL|B3GNT8|B9D2|BBC3|BCAM|BCKDHA|BCL3|BICRA|BLOC1S3|BLVRB|BSPH1|C19orf12|C19orf33|C19orf47|C5AR1|C5AR2|CA11|CABP5|CADM4|CALM3|CAPN12|CAPNS1|CARD8|CATSPERG|CBLC|CCDC61|CCDC8|CCDC9|CCDC97|CCNE1|CCNP|CD177|CD22|CD79A|CEACAM1|CEACAM16|CEACAM19|CEACAM20|CEACAM21|CEACAM3|CEACAM4|CEACAM5|CEACAM6|CEACAM7|CEACAM8|CEBPA|CEBPG|CEP89|CHST8|CIC|CKM|CLASRP|CLC|CLIP3|CLPTM1|CNFN|COQ8B|COX6B1|COX7A1|CRX|CXCL17|CYP2A13|CYP2A6|CYP2A7|CYP2B6|CYP2F1|CYP2S1|CYTH2|DACT3|DBP|DEDD2|DHX34|DLL3|DMAC2|DMKN|DMPK|DMRTC2|DMWD|DPF1|DPY19L3|DYRK1B|ECH1|EGLN2|EHD2|EID2|EID2B|EIF3K|ELSPBP1|EML2|EMP3|ERCC1|ERCC2|ERF|ERICH4|ETHE1|ETV2|EXOC3L2|EXOSC5|FAAP24|FAM187B|FAM83E|FAM98C|FBL|FBXO17|FBXO27|FBXO46|FCGBP|FFAR1|FFAR2|FFAR3|FKRP|FOSB|FOXA3|FUT2|FXYD1|FXYD3|FXYD5|FXYD7|GAPDHS|GARRE1|GEMIN7|GGN|GIPR|GMFG|GNG8|GPATCH1|GPI|GPR4|GPR42|GRAMD1A|GRIK5|GRIN2D|GRWD1|GSK3A|HAMP|HAUS5|HCST|HIF3A|HIPK4|HNRNPL|HNRNPUL1|HPN|HSPB6|IFNL1|IFNL2|IFNL3|IGFL1|IGFL2|IGFL3|IGFL4|IGFLR1|IGSF23|INAFM1|IRF2BP1|IRGC|IRGQ|ITPKC|KCNJ14|KCNK6|KCNN4|KCTD15|KDELR1|KIRREL2|KLC3|KMT2B|KPTN|KRTDAP|LEUTX|LGALS13|LGALS14|LGALS16|LGALS4|LGALS7|LGALS7B|LGI4|LIG1|LIN37|LIPE|LMTK3|LRFN1|LRFN3|LRP3|LSM14A|LSR|LTBP4|LYPD3|LYPD4|LYPD5|MAG|MAP3K10|MAP4K1|MARK4|MED29|MEGF8|MEIS3|MIA|MRPS12|MYPOP|NANOS2|NAPA|NCCRP1|NECTIN2|NFKBIB|NFKBID|NKPD1|NOP53|NOVA2|NPAS1|NPHS1|NTN5|NUDT19|NUMBL|ODAD1|OPA3|OVOL3|PAF1|PAFAH1B3|PAK4|PDCD2L|PDCD5|PEPD|PGLYRP1|PHLDB3|PINLYP|PLA2G4C|PLAUR|PLD3|PLEKHF1|PLEKHG2|PNMA8A|PNMA8B|POLR1G|POLR2I|POP4|POU2F2|PPM1N|PPP1R13L|PPP1R14A|PPP1R37|PPP5C|PPP5D1|PRG1|PRKD2|PRODH2|PROSER3|PRR19|PRX|PSENEN|PSG1|PSG11|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG9|PSMC4|PSMD8|PTGIR|PVR|QPCTL|RAB4B|RABAC1|RASGRP4|RBM42|RELB|RGS9BP|RHPN2|RINL|RPL18|RPS16|RPS19|RSPH6A|RTN2|RYR1|SAE1|SAMD4B|SARS2|SBSN|SCGB2B2|SERTAD3|SCN1B|SDHAF1|SELENOV|SELENOW|SERTAD1|SHKBP1|SIPA1L3|SIRT2|SIX5|SLC1A5|SLC7A10|SLC7A9|SLC8A2|SMG9|SNRPA|SNRPD2|SPACA4|SPHK2|SPINT2|SPRED3|SPTBN4|SRRM5|STRN4|SULT2A1|SULT2B1|SUPT5H|SYCN|SYMPK|SYNE4|SYNGR4|TBCB|TDRD12|TEX101|TGFB1|THAP8|TIMM50|TMEM143|TMEM145|TMEM147|TMEM160|TMEM91|TOMM40|TPRX1|TRAPPC6A|TRU-TCA1-1|TSHZ3|TTC9B|TYROBP|U2AF1L4|UBA2|UPK1A|UQCRFS1|URI1|USF2|VASP|VSTM2B|WDR62|WDR87|WDR88|WTIP|XRCC1|YIF1B|ZBTB32|ZC3H4|ZFP14|ZFP30|ZFP36|ZFP82|ZNF112|ZNF114|ZNF146|ZNF155|ZNF180|ZNF181|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF260|ZNF283|ZNF284|ZNF285|ZNF296|ZNF30|ZNF302|ZNF345|ZNF382|ZNF383|ZNF404|ZNF420|ZNF428|ZNF45|ZNF461|ZNF507|ZNF526|ZNF527|ZNF529|ZNF536|ZNF540|ZNF541|ZNF546|ZNF565|ZNF566|ZNF567|ZNF568|ZNF569|ZNF570|ZNF571|ZNF573|ZNF574|ZNF575|ZNF576|ZNF585A|ZNF585B|ZNF599|ZNF607|ZNF780A|ZNF780B|ZNF781|ZNF790|ZNF792|ZNF793|ZNF829|ZNF850|ZNF875|ZSWIM9		not provided	VCV000685025	19	28271106 - 49213832			685025	672617			copy number gain		Pathogenic	Oct 13, 2017	no assertion criteria provided							
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)	PKN1|PLA2G4C|PLAUR|PLD3|PLEKHA4|PLEKHF1|PLEKHG2|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|PLVAP|PNKP|PNMA8A|PNMA8B|PNPLA6|PODNL1|POLD1|POLR1G|POLR2E|POLR2I|POLRMT|POP4|POU2F2|PPAN|PPAN-P2RY11|PPFIA3|PPM1N|PPP1R12C|PPP1R13L|PPP1R14A|PPP1R15A|PPP1R37|PPP2R1A|PPP5C|PPP5D1|PPP6R1|PRAM1|PRDX2|PRG1|PRKACA|PRKCG|PRKCSH|PRKD2|PRMT1|PRODH2|PROSER3|PRPF31|PRR12|PRR19|PRR22|PRRG2|PRSS57|PRTN3|PRX|PSENEN|PSG1|PSG11|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG9|PSMC4|PSMD8|PSPN|PTBP1|PTGER1|PTGIR|PTH2|PTOV1|PTOV1-AS2|PTPRH|PTPRS|PVR|PWWP3A|QPCTL|QTRT1|R3HDM4|RAB11B|RAB3A|RAB3D|RAB4B|RAB8A|RABAC1|RAD23A|RANBP3|RASAL3|RASGRP4|RASIP1|RAVER1|RAX2|RBM42|RCN3|RDH13|RDH8|REEP6|RELB|RETN|REX1BD|REXO1|RFPL4A|RFPL4AL1|RFX1|RFX2|RFXANK|RGL3|RGS9BP|RHPN2|RINL|RLN3|RNASEH2A|RNF126|RPL13A|RPL18|RPL18A|RPL28|RPL36|RPS11|RPS15|RPS16|RPS19|RPS28|RPS5|RPS9|RRAS|RSPH6A|RTBDN|RTN2|RUVBL2|RYR1|S1PR2|S1PR4|S1PR5|SAE1|SAFB|SAFB2|SAMD1|SAMD4B|SARS2|SAXO5|SBK2|SBNO2|SBSN|SCAF1|SCAMP4|SCGB2B2|SCN1B|SDHAF1|SELENOV|SELENOW|SEMA6B|SERTAD1|SERTAD3|SF3A2|SGTA|SH2D3A|SH3GL1|SHANK1|SHC2|SHD|SHFL|SHISA7|SHKBP1|SIGLEC10|SIGLEC11|SIGLEC12|SIGLEC14|SIGLEC5|SIGLEC6|SIGLEC7|SIGLEC8|SIGLEC9|SIGLECL1|SIN3B|SIPA1L3|SIRT2|SIRT6|SIX5|SLC17A7|SLC1A5|SLC1A6|SLC25A23|SLC25A41|SLC25A42|SLC27A1|SLC35E1|SLC39A3|SLC44A2|SLC5A5|SLC6A16|SLC7A10|SLC7A9|SLC8A2|SMARCA4|SMG9|SMIM17|SMIM24|SMIM7|SNAPC2|SNRNP70|SNRPA|SNRPD2|SPACA4|SPC24|SPHK2|SPIB|SPINT2|SPMAP2|SPPL2B|SPRED3|SPTBN4|SRRM5|SSBP4|SSC5D|STAP2|STK11|STRN4|STX10|STXBP2|SUGP1|SUGP2|SULT2A1|SULT2B1|SUPT5H|SWSAP1|SYCE2|SYCN|SYDE1|SYMPK|SYNE4|SYNGR4|SYT3|SYT5|TARM1|TBC1D17|TBCB|TBXA2R|TCF3|TDRD12|TEAD2|TECR|TEKTIP1|TEKTL1|TEX101|TFPT|TGFB1|TGFBR3L|THAP8|THOP1|TICAM1|TIMM13|TIMM29|TIMM44|TIMM50|TINCR|TJP3|TLE2|TLE5|TLE6|TM6SF2|TMC4|TMED1|TMEM143|TMEM145|TMEM147|TMEM150B|TMEM160|TMEM161A|TMEM190|TMEM205|TMEM221|TMEM238|TMEM259|TMEM38A|TMEM59L|TMEM86B|TMEM91|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TNNI3|TNNT1|TNPO2|TOMM40|TPGS1|TPM4|TPRX1|TRAPPC5|TRAPPC6A|TRIP10|TRIR|TRMT1|TRPM4|TRU-TCA1-1|TSEN34|TSHZ3|TSKS|TSPAN16|TSSK6|TTC9B|TTYH1|TUBB4A|TULP2|TYK2|TYROBP|U2AF1L4|U2AF2|UBA2|UBA52|UBE2S|UBL5|UBXN6|UCA1|UHRF1|UNC13A|UPF1|UPK1A|UQCR11|UQCRFS1|URI1|USE1|USF2|USHBP1|USP29|VASP|VAV1|VMAC|VN1R1|VN1R2|VN1R4|VRK3|VSIG10L|VSTM1|VSTM2B|WDR18|WDR62|WDR83|WDR83OS|WDR87|WDR88|WIZ|WTIP|XAB2|XRCC1|YIF1B|YIPF2|YJEFN3|YJU2|YJU2B|ZBTB32|ZBTB7A|ZC3H4|ZFP14|ZFP28|ZFP30|ZFP36|ZFP82|ZFR2|ZGLP1|ZIK1|ZIM2|ZIM2-AS1|ZIM3|ZNF100|ZNF101|ZNF112|ZNF114|ZNF121|ZNF132|ZNF134|ZNF135|ZNF136|ZNF14|ZNF146|ZNF154|ZNF155|ZNF160|ZNF17|ZNF175|ZNF177|ZNF180|ZNF181|ZNF20|ZNF208|ZNF211|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF253|ZNF254|ZNF256|ZNF257|ZNF260|ZNF264|ZNF266|ZNF274|ZNF28|ZNF283|ZNF284|ZNF285|ZNF296|ZNF30|ZNF302|ZNF304|ZNF317|ZNF320|ZNF329|ZNF331|ZNF333|ZNF345|ZNF347|ZNF350|ZNF358|ZNF382|ZNF383|ZNF404|ZNF414|ZNF415|ZNF416|ZNF417|ZNF418|ZNF419|ZNF420|ZNF426|ZNF428|ZNF429|ZNF43|ZNF430|ZNF431|ZNF432|ZNF433|ZNF439|ZNF44|ZNF440|ZNF441|ZNF442|ZNF443|ZNF444|ZNF45|ZNF460|ZNF461|ZNF468|ZNF470|ZNF471|ZNF473|ZNF480|ZNF486|ZNF490|ZNF491|ZNF492|ZNF493|ZNF497|ZNF506|ZNF507|ZNF524|ZNF526|ZNF527|ZNF528|ZNF529|ZNF530|ZNF534|ZNF536|ZNF540|ZNF541|ZNF543|ZNF544|ZNF546|ZNF547|ZNF548|ZNF549|ZNF550|ZNF551|ZNF552|ZNF554|ZNF555|ZNF556|ZNF557|ZNF558|ZNF559|ZNF559-ZNF177|ZNF560|ZNF561|ZNF562|ZNF563|ZNF564|ZNF565|ZNF566|ZNF567|ZNF568|ZNF569|ZNF570|ZNF571|ZNF573|ZNF574|ZNF575|ZNF576|ZNF577|ZNF578|ZNF579|ZNF580|ZNF581|ZNF582|ZNF583|ZNF584|ZNF585A|ZNF585B|ZNF586|ZNF587|ZNF587B|ZNF599|ZNF600|ZNF606|ZNF607|ZNF610|ZNF611|ZNF613|ZNF614|ZNF615|ZNF616|ZNF625|ZNF626|ZNF627|ZNF628|ZNF649|ZNF653|A1BG|ABCA7|ABHD17A|ABHD8|ACER1|ACP4|ACP5|ACP7|ACSBG2|ACTL9|ACTMAP|ACTN4|ADAMTS10|ADAMTSL5|ADAT3|ADGRE1|ADGRE2|ADGRE3|ADGRE5|ADGRL1|ADM5|AKAP8|AKAP8L|AKT1S1|AKT2|ALDH16A1|ALKBH6|ALKBH7|AMH|ANGPTL4|ANGPTL6|ANGPTL8|ANKLE1|ANKRD24|ANKRD27|ANO8|AP1M1|AP1M2|AP2A1|AP2S1|AP3D1|APBA3|APC2|APLP1|APOC1|APOC2|APOC4|APOE|ARHGAP33|ARHGAP35|ARHGAP45|ARHGEF1|ARHGEF18|ARID3A|ARMC6|ARRDC2|ARRDC5|ASF1B|ASPDH|ATCAY|ATF5|ATG4D|ATP13A1|ATP1A3|ATP4A|ATP5F1D|ATP8B3|AURKC|AXL|AZU1|B3GNT3|B3GNT8|B9D2|BABAM1|BAX|BBC3|BCAM|BCAT2|BCKDHA|BCL2L12|BCL3|BEST2|BICRA|BLOC1S3|BLVRB|BORCS8|BRD4|BRME1|BRSK1|BSG|BSPH1|BST2|BTBD2|C19orf12|C19orf18|C19orf25|C19orf33|C19orf38|C19orf44|C19orf47|C19orf53|C19orf67|C19orf73|C19orf81|C2CD4C|C3|C5AR1|C5AR2|CA11|CABP5|CACNA1A|CACNG6|CACNG7|CACNG8|CACTIN|CADM4|CALM3|CALR|CALR3|CAMSAP3|CAPN12|CAPNS1|CAPS|CARD8|CARM1|CASP14|CATSPERD|CATSPERG|CBARP|CBLC|CC2D1A|CCDC106|CCDC124|CCDC159|CCDC61|CCDC8|CCDC9|CCDC97|CCL25|CCNE1|CCNP|CD177|CD209|CD22|CD320|CD33|CD37|CD70|CD79A|CDC34|CDC37|CDC42EP5|CDKN2D|CEACAM1|CEACAM16|CEACAM18|CEACAM19|CEACAM20|CEACAM21|CEACAM3|CEACAM4|CEACAM5|CEACAM6|CEACAM7|CEACAM8|CEBPA|CEBPG|CELF5|CEP89|CERS1|CERS4|CFD|CGB1|CGB2|CGB3|CGB5|CGB7|CGB8|CHAF1A|CHERP|CHST8|CIB3|CIC|CILP2|CIMAP1D|CIRBP|CKM|CLASRP|CLC|CLDND2|CLEC11A|CLEC17A|CLEC4G|CLEC4M|CLIP3|CLPP|CLPTM1|CNFN|CNN1|CNN2|CNOT3|COL5A3|COLGALT1|COMP|COPE|COQ8B|COX6B1|COX6B2|COX7A1|CPAMD8|CPT1C|CRB3|CREB3L3|CRLF1|CRTC1|CRX|CSNK1G2|CTU1|CTXN1|CXCL17|CYP2A13|CYP2A6|CYP2A7|CYP2B6|CYP2F1|CYP2S1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|CYTH2|DACT3|DAND5|DAPK3|DAZAP1|DBP|DCAF15|DDA1|DDX39A|DDX49|DEDD2|DENND1C|DHDH|DHPS|DHX34|DIRAS1|DKKL1|DLL3|DMAC2|DMKN|DMPK|DMRTC2|DMWD|DNAAF3|DNAJB1|DNASE2|DNM2|DNMT1|DOCK6|DOHH|DOT1L|DPF1|DPP9|DPRX|DPY19L3|DUS3L|DUXA|DYRK1B|EBI3|ECH1|ECSIT|EEF2|EFNA2|EGLN2|EHD2|EID2|EID2B|EIF3G|EIF3K|ELANE|ELAVL1|ELAVL3|ELL|ELOF1|ELSPBP1|EMC10|EML2|EMP3|EPHX3|EPN1|EPOR|EPS15L1|EPS8L1|ERCC1|ERCC2|ERF|ERICH4|ERVV-1|ERVV-2|ETFB|ETHE1|ETV2|EVI5L|EXOC3L2|EXOSC5|F2RL3|FAAP24|FAM174C|FAM187B|FAM32A|FAM83E|FAM98C|FARSA|FBL|FBN3|FBXL12|FBXO17|FBXO27|FBXO46|FBXW9|FCAR|FCER2|FCGBP|FCGRT|FCHO1|FDX2|FEM1A|FFAR1|FFAR2|FFAR3|FGF21|FGF22|FIZ1|FKBP8|FKRP|FLT3LG|FOSB|FOXA3|FPR1|FPR2|FPR3|FSD1|FSTL3|FTL|FUT1|FUT2|FUT3|FUT5|FUT6|FUZ|FXYD1|FXYD3|FXYD5|FXYD7|FZR1|GADD45B|GADD45GIP1|GALP|GAMT|GAPDHS|GARIN5A|GARIN5B|GARRE1|GATAD2A|GCDH|GDF1|GDF15|GEMIN7|GET3|GGN|GIPC1|GIPC3|GIPR|GMFG|GMIP|GNA11|GNA15|GNG7|GNG8|GP6|GPATCH1|GPI|GPR108|GPR32|GPR4|GPR42|GPX4|GRAMD1A|GRIK5|GRIN2D|GRIN3B|GRWD1|GSK3A|GTF2F1|GTPBP3|GYS1|GZMM|HACL2|HAMP|HAPLN4|HAS1|HAUS5|HAUS8|HCN2|HCST|HIF3A|HIPK4|HMG20B|HNRNPL|HNRNPM|HNRNPUL1|HOMER3|HOOK2|HPN|HRC|HSD11B1L|HSD17B14|HSH2D|HSPB6|HSPBP1|ICAM1|ICAM3|ICAM4|ICAM5|IER2|IFI30|IFNL1|IFNL2|IFNL3|IGFL1|IGFL2|IGFL3|IGFL4|IGFLR1|IGLON5|IGSF23|IL11|IL12RB1|IL27RA|IL4I1|ILF3|INAFM1|INSL3|INSR|IQCN|IRF2BP1|IRF3|IRGC|IRGQ|ISOC2|ISYNA1|ITPKC|IZUMO1|IZUMO2|IZUMO4|JAK3|JOSD2|JSRP1|JUNB|JUND|KANK2|KANK3|KASH5|KCNA7|KCNC3|KCNJ14|KCNK6|KCNN1|KCNN4|KCTD15|KDELR1|KDM4B|KEAP1|KHSRP|KIRREL2|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KIR3DL3|KISS1R|KLC3|KLF1|KLF16|KLF2|KLHL26|KLK1|KLK10|KLK11|KLK12|KLK13|KLK14|KLK15|KLK2|KLK3|KLK4|KLK5|KLK6|KLK7|KLK8|KLK9|KMT2B|KMT5C|KPTN|KRI1|KRTDAP|KXD1|LAIR1|LAIR2|LDLR|LENG1|LENG8|LENG9|LEUTX|LGALS13|LGALS14|LGALS16|LGALS4|LGALS7|LGALS7B|LGI4|LHB|LIG1|LILRA1|LILRA2|LILRA3|LILRA4|LILRA5|LILRA6|LILRB1|LILRB2|LILRB3|LILRB4|LILRB5|LIM2|LIN37|LIN7B|LINGO3|LIPE|LMNB2|LMTK3|LONP1|LPAR2|LRFN1|LRFN3|LRG1|LRP3|LRRC25|LRRC4B|LRRC8E|LSM14A|LSM4|LSM7|LSR|LTBP4|LYL1|LYPD3|LYPD4|LYPD5|MADCAM1|MAG|MAMSTR|MAN2B1|MAP1S|MAP2K2|MAP2K7|MAP3K10|MAP4K1|MARCHF2|MARK4|MAST1|MAST3|MATK|MAU2|MBD3|MBD3L1|MBD3L2|MBD3L3|MBD3L4|MBD3L5|MBOAT7|MCEMP1|MCOLN1|MED16|MED25|MED26|MED29|MEF2B|MEGF8|MEIS3|MEX3D|MFSD12|MIA|MICOS13|MIDN|MIER2|MIR125A|MIR150|MIR181C|MIR1909|MIR199A1|MIR23A|MIR24-2|MIR27A|MIR371A|MIR372|MIR373|MIR519D|MIR520H|MIR99B|MIRLET7E|MISP|MKNK2|MLLT1|MOB3A|MPND|MPV17L2|MRI1|MRPL34|MRPL4|MRPL54|MRPS12|MUC16|MVB12A|MYADM|MYBPC2|MYDGF|MYH14|MYO1F|MYO9B|MYPOP|NACC1|NANOS2|NANOS3|NAPA|NAPSA|NAT14|NCAN|NCCRP1|NCLN|NCR1|NDUFA11|NDUFA13|NDUFA3|NDUFA7|NDUFB7|NDUFS7|NECTIN2|NFIC|NFIX|NFKBIB|NFKBID|NIBAN3|NKG7|NKPD1|NLRP11|NLRP12|NLRP13|NLRP2|NLRP4|NLRP5|NOSIP|NLRP7|NLRP8|NLRP9|NMRK2|NOP53|NOTCH3|NOVA2|NPAS1|NPHS1|NR1H2|NR2C2AP|NR2F6|NRTN|NTF4|NTN5|NUCB1|NUDT19|NUMBL|NUP62|NWD1|NXNL1|OAZ1|OCEL1|ODAD1|ODAD3|OLFM2|ONECUT3|OPA3|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|OR1I1|OR1M1|OR2Z1|OR7A10|OR7A17|OR7A5|OR7C1|OR7C2|OR7D2|OR7D4|OR7E24|OR7G1|OR7G2|OR7G3|OSCAR|OVOL3|P2RY11|PAF1|PAFAH1B3|PAK4|PALM|PALM3|PBX4|PCP2|PCSK4|PDCD2L|PDCD5|PDE4A|PDE4C|PEAK3|PEG3|PEPD|PET100|PEX11G|PGLS|PGLS-DT|PGLYRP1|PGLYRP2|PGPEP1|PHLDB3|PIAS4|PIH1D1|PIK3R2|PIN1|PINLYP|PIP5K1C|ZNF665|ZNF667|ZNF671|ZNF675|ZNF676|ZNF677|ZNF681|ZNF682|ZNF69|ZNF699|ZNF700|ZNF701|ZNF708|ZNF709|ZNF71|ZNF714|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF749|ZNF761|ZNF763|ZNF765|ZNF766|ZNF77|ZNF772|ZNF773|ZNF776|ZNF780A|ZNF780B|ZNF781|ZNF784|ZNF787|ZNF790|ZNF791|ZNF792|ZNF793|ZNF799|ZNF8|ZNF805|ZNF808|ZNF813|ZNF814|ZNF816|ZNF816-ZNF321P|ZNF823|ZNF829|ZNF83|ZNF835|ZNF836|ZNF837|ZNF841|ZNF844|ZNF845|ZNF846|ZNF85|ZNF850|ZNF865|ZNF875|ZNF878|ZNF880|ZNF888|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99|ZNRF4|ZSCAN1|ZSCAN18|ZSCAN22|ZSCAN4|ZSCAN5A|ZSCAN5B|ZSWIM4|ZSWIM9		See cases	VCV000443499	19	260912 - 58956888			443499	437161			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)x3	A1BG|ABCA7|ABHD17A|ABHD8|ACER1|ACP4|ACP5|ACP7|ACSBG2|ACTL9|ACTMAP|ACTN4|ADAMTS10|ADAMTSL5|ADAT3|ADGRE1|ADGRE2|ADGRE3|ADGRE5|ADGRL1|ADM5|AKAP8|AKAP8L|AKT1S1|AKT2|ALDH16A1|ALKBH6|ALKBH7|AMH|ANGPTL4|ANGPTL6|ANGPTL8|ANKLE1|ANKRD24|ANKRD27|ANO8|AP1M1|AP1M2|AP2A1|AP2S1|AP3D1|APBA3|APC2|APLP1|APOC1|APOC2|APOC4|APOE|ARHGAP33|ARHGAP35|ARHGAP45|ARHGEF1|ARHGEF18|ARID3A|ARMC6|ARRDC2|ARRDC5|ASF1B|ASPDH|ATCAY|ATF5|ATG4D|ATP13A1|ATP1A3|ATP4A|ATP5F1D|ATP8B3|AURKC|AXL|AZU1|B3GNT3|B3GNT8|B9D2|BABAM1|BAX|BBC3|BCAM|BCAT2|BCKDHA|BCL2L12|BCL3|BEST2|BICRA|BLOC1S3|BLVRB|BORCS8|BRD4|BRME1|BRSK1|BSG|BSPH1|BST2|BTBD2|C19orf12|C19orf18|C19orf25|C19orf33|C19orf38|C19orf44|C19orf47|C19orf53|C19orf67|C19orf73|C19orf81|C2CD4C|C3|C5AR1|C5AR2|CA11|CABP5|CACNA1A|CACNG6|CACNG7|CACNG8|CACTIN|CADM4|CALM3|CALR|CALR3|CAMSAP3|CAPN12|CAPNS1|CAPS|CARD8|CARM1|CASP14|CATSPERD|CATSPERG|CBARP|CBLC|CC2D1A|CCDC106|CCDC124|CCDC159|CCDC61|CCDC8|CCDC9|CCDC97|CCL25|CCNE1|CCNP|CD177|CD209|CD22|CD320|CD33|CD37|CD70|CD79A|CDC34|CDC37|CDC42EP5|CDKN2D|CEACAM1|CEACAM16|CEACAM18|CEACAM19|CEACAM20|CEACAM21|CEACAM3|CEACAM4|CEACAM5|CEACAM6|CEACAM7|CEACAM8|CEBPA|CEBPG|CELF5|CEP89|CERS1|CERS4|CFD|CGB1|CGB2|CGB3|CGB5|CGB7|CGB8|CHAF1A|CHERP|CHST8|CIB3|CIC|CILP2|CIMAP1D|CIRBP|CKM|CLASRP|CLC|CLDND2|CLEC11A|CLEC17A|CLEC4G|CLEC4M|CLIP3|CLPP|CLPTM1|CNFN|CNN1|CNN2|CNOT3|COL5A3|COLGALT1|COMP|COPE|COQ8B|COX6B1|COX6B2|COX7A1|CPAMD8|CPT1C|CRB3|CREB3L3|CRLF1|CRTC1|CRX|CSNK1G2|CTU1|CTXN1|CXCL17|CYP2A13|CYP2A6|CYP2A7|CYP2B6|CYP2F1|CYP2S1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|CYTH2|DACT3|DAND5|DAPK3|DAZAP1|DBP|DCAF15|DDA1|DDX39A|DDX49|DEDD2|DENND1C|DHDH|DHPS|DHX34|DIRAS1|DKKL1|DLL3|DMAC2|DMKN|DMPK|DMRTC2|DMWD|DNAAF3|DNAJB1|DNASE2|DNM2|DNMT1|DOCK6|DOHH|DOT1L|DPF1|DPP9|DPRX|DPY19L3|DUS3L|DUXA|DYRK1B|EBI3|ECH1|ECSIT|EEF2|EFNA2|EGLN2|EHD2|EID2|EID2B|EIF3G|EIF3K|EMC10|ELANE|ELAVL1|ELAVL3|ELL|ELOF1|ELSPBP1|EML2|EMP3|EPHX3|EPN1|EPOR|EPS15L1|EPS8L1|ERCC1|ERCC2|ERF|ERICH4|ERVV-1|ERVV-2|ETFB|ETHE1|ETV2|EVI5L|EXOC3L2|EXOSC5|F2RL3|FAAP24|FAM174C|FAM187B|FAM32A|FAM83E|FAM98C|FARSA|FBL|FBN3|FBXL12|FBXO17|FBXO27|FBXO46|FBXW9|FCAR|FCER2|FCGBP|FCGRT|FCHO1|FDX2|FEM1A|FFAR1|FFAR2|FFAR3|FGF21|FGF22|FIZ1|FKBP8|FKRP|FLT3LG|FOSB|FOXA3|FPR1|FPR2|FPR3|FSD1|FSTL3|FTL|FUT1|FUT2|FUT3|FUT5|FUT6|FUZ|FXYD1|FXYD3|FXYD5|FXYD7|FZR1|GADD45B|GADD45GIP1|GALP|GAMT|GAPDHS|GARIN5A|GARIN5B|GARRE1|GATAD2A|GCDH|GDF1|GDF15|GEMIN7|GET3|GGN|GIPC1|GIPC3|GIPR|GMFG|GMIP|GNA11|GNA15|GNG7|GNG8|GP6|GPATCH1|GPI|GPR108|GPR32|GPR4|GPR42|GPX4|GRAMD1A|GRIK5|GRIN2D|GRIN3B|GRWD1|GSK3A|GTF2F1|GTPBP3|GYS1|GZMM|HACL2|HAMP|HAPLN4|HAS1|HAUS5|HAUS8|HCN2|HCST|HIF3A|HIPK4|HMG20B|HNRNPL|HNRNPM|HNRNPUL1|HOMER3|HOOK2|HPN|HRC|HSD11B1L|HSD17B14|HSH2D|HSPB6|HSPBP1|ICAM1|ICAM3|ICAM4|ICAM5|IER2|IFI30|IFNL1|IFNL2|IFNL3|IGFL1|IGFL2|IGFL3|IGFL4|IGFLR1|IGLON5|IGSF23|IL11|IL12RB1|IL27RA|IL4I1|ILF3|INAFM1|INSL3|INSR|IQCN|IRF2BP1|IRF3|IRGC|IRGQ|ISOC2|ISYNA1|ITPKC|IZUMO1|IZUMO2|IZUMO4|JAK3|JOSD2|JSRP1|JUNB|JUND|KANK2|KANK3|KASH5|KCNA7|KCNC3|KCNJ14|KCNK6|KCNN1|KCNN4|KCTD15|KDELR1|KDM4B|KEAP1|KHSRP|KIRREL2|KISS1R|KLC3|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KIR3DL3|KLF1|KLF16|KLF2|KLHL26|KLK1|KLK10|KLK11|KLK12|KLK13|KLK14|KLK15|KLK2|KLK3|KLK4|KLK5|KLK6|KLK7|KLK8|KLK9|KMT2B|KMT5C|KPTN|KRI1|TPGS1|TPM4|TPRX1|TRAPPC5|TRAPPC6A|TRIP10|TRIR|TRMT1|TRPM4|TRU-TCA1-1|TSEN34|TSHZ3|TSKS|TSPAN16|TSSK6|TTC9B|TTYH1|TUBB4A|TULP2|TYK2|TYROBP|U2AF1L4|U2AF2|UBA2|UBA52|UBE2S|UBL5|UBXN6|UCA1|UHRF1|UNC13A|UPF1|UPK1A|UQCR11|UQCRFS1|URI1|USE1|USF2|USHBP1|USP29|VASP|VAV1|VMAC|VN1R1|VN1R2|VN1R4|VRK3|VSIG10L|WDR83OS|VSTM1|VSTM2B|WDR18|WDR62|WDR83|WDR87|WDR88|WIZ|WTIP|XAB2|XRCC1|YIF1B|YIPF2|YJEFN3|YJU2|YJU2B|ZBTB32|ZBTB7A|ZC3H4|ZFP14|ZFP28|ZFP30|ZFP36|ZFP82|ZFR2|ZGLP1|ZIK1|ZIM2|ZIM2-AS1|ZIM3|ZNF100|ZNF101|ZNF112|ZNF114|ZNF121|ZNF132|ZNF134|ZNF135|ZNF136|ZNF14|ZNF146|ZNF154|ZNF155|ZNF160|ZNF17|ZNF175|ZNF177|ZNF180|ZNF181|ZNF20|ZNF208|ZNF211|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF253|ZNF254|ZNF256|ZNF257|ZNF260|ZNF264|ZNF266|ZNF274|ZNF28|ZNF283|ZNF284|ZNF285|ZNF296|ZNF30|ZNF302|ZNF304|ZNF317|ZNF320|ZNF329|ZNF331|ZNF333|ZNF345|ZNF347|ZNF350|ZNF358|ZNF382|ZNF383|ZNF404|ZNF414|ZNF415|ZNF416|ZNF417|ZNF418|ZNF419|ZNF420|ZNF426|ZNF428|ZNF429|ZNF43|ZNF430|ZNF431|ZNF432|ZNF433|ZNF439|ZNF44|ZNF440|ZNF441|ZNF442|ZNF443|ZNF444|ZNF45|ZNF460|ZNF461|ZNF468|ZNF470|ZNF471|ZNF473|ZNF480|ZNF486|ZNF490|ZNF491|ZNF492|ZNF493|ZNF497|ZNF506|ZNF507|ZNF524|ZNF526|ZNF527|ZNF528|ZNF529|ZNF530|ZNF534|ZNF536|ZNF540|ZNF541|ZNF543|ZNF544|ZNF546|ZNF547|ZNF548|ZNF549|ZNF550|ZNF551|ZNF552|ZNF554|ZNF555|ZNF556|ZNF557|ZNF558|ZNF559|ZNF559-ZNF177|ZNF560|ZNF561|ZNF562|ZNF563|ZNF564|ZNF565|ZNF566|ZNF567|ZNF568|ZNF569|ZNF570|ZNF571|ZNF573|ZNF574|ZNF575|ZNF576|ZNF577|ZNF578|ZNF579|ZNF580|ZNF581|ZNF582|ZNF583|ZNF584|ZNF585A|ZNF585B|ZNF586|ZNF587|ZNF587B|ZNF599|ZNF600|ZNF606|ZNF607|ZNF610|ZNF611|ZNF613|ZNF614|ZNF615|ZNF616|ZNF625|ZNF626|ZNF627|ZNF628|ZNF649|ZNF653|ZNF665|ZNF667|ZNF671|ZNF675|ZNF676|ZNF677|ZNF681|ZNF682|ZNF69|ZNF699|ZNF700|ZNF701|ZNF708|ZNF709|ZNF71|ZNF714|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF749|ZNF761|ZNF763|ZNF765|ZNF766|ZNF77|ZNF772|ZNF773|ZNF776|ZNF780A|ZNF780B|ZNF781|ZNF784|ZNF787|ZNF790|ZNF791|ZNF792|ZNF793|ZNF799|ZNF8|ZNF805|ZNF808|ZNF813|ZNF814|ZNF816|ZNF816-ZNF321P|ZNF823|ZNF829|ZNF83|ZNF835|ZNF836|ZNF837|ZNF841|ZNF844|ZNF845|ZNF846|ZNF85|ZNF850|ZNF865|ZNF875|ZNF878|ZNF880|ZNF888|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99|ZNRF4|ZSCAN1|ZSCAN18|ZSCAN22|ZSCAN4|ZSCAN5A|ZSCAN5B|ZSWIM4|ZSWIM9|KRTDAP|KXD1|LAIR1|LAIR2|LDLR|LENG1|LENG8|LENG9|LEUTX|LGALS13|LGALS14|LGALS16|LGALS4|LGALS7|LGALS7B|LGI4|LHB|LIG1|LILRA1|LILRA2|LILRA3|LILRA4|LILRA5|LILRA6|LILRB1|LILRB2|LILRB3|LILRB4|LILRB5|LIM2|LIN37|LIN7B|LINGO3|LIPE|LMNB2|LMTK3|LONP1|LPAR2|LRFN1|LRFN3|LRG1|LRP3|LRRC25|LRRC4B|LRRC8E|LSM14A|LSM4|LSM7|LSR|LTBP4|LYL1|LYPD3|LYPD4|LYPD5|MADCAM1|MAG|MAMSTR|MAN2B1|MAP1S|MAP2K2|MAP2K7|MAP3K10|MAP4K1|MARCHF2|MARK4|MAST1|MAST3|MATK|MAU2|MBD3|MBD3L1|MBD3L2|MBD3L3|MBD3L4|MBD3L5|MBOAT7|MCEMP1|MCOLN1|MED16|MED25|MED26|MED29|MEF2B|MEGF8|MEIS3|MEX3D|MFSD12|MIA|MICOS13|MIDN|MIER2|MIR125A|MIR150|MIR181C|MIR1909|MIR199A1|MIR23A|MIR24-2|MIR27A|MIR371A|MIR372|MIR373|MIR519D|MIR520H|MIR99B|MIRLET7E|MISP|MKNK2|MLLT1|MOB3A|MPND|MPV17L2|MRI1|MRPL34|MRPL4|MRPL54|MRPS12|MUC16|MVB12A|MYADM|MYBPC2|MYDGF|MYH14|MYO1F|MYO9B|MYPOP|NACC1|NANOS2|NANOS3|NAPA|NAPSA|NAT14|NCAN|NCCRP1|NCLN|NCR1|NDUFA11|NDUFA13|NDUFA3|NDUFA7|NDUFB7|NDUFS7|NECTIN2|NFIC|NFIX|NFKBIB|NFKBID|NIBAN3|NKG7|NKPD1|NLRP11|NLRP12|NLRP13|NLRP2|NLRP4|NLRP5|NOSIP|NLRP7|NLRP8|NLRP9|NMRK2|NOP53|NOTCH3|NOVA2|NPAS1|NPHS1|NR1H2|NR2C2AP|NR2F6|NRTN|NTF4|NTN5|NUCB1|NUDT19|NUMBL|NUP62|NWD1|NXNL1|OAZ1|OCEL1|ODAD1|ODAD3|OLFM2|ONECUT3|OPA3|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|OR1I1|OR1M1|OR2Z1|OR7A10|OR7A17|OR7A5|OR7C1|OR7C2|OR7D2|OR7D4|OR7E24|OR7G1|OR7G2|OR7G3|OSCAR|OVOL3|P2RY11|PAF1|PAFAH1B3|PAK4|PALM|PALM3|PBX4|PCP2|PCSK4|PDCD2L|PDCD5|PDE4A|PDE4C|PEAK3|PEG3|PEPD|PET100|PEX11G|PGLS|PGLS-DT|PGLYRP1|PGLYRP2|PGPEP1|PHLDB3|PIAS4|PIH1D1|PIK3R2|PIN1|PINLYP|PIP5K1C|PKN1|PLA2G4C|PLAUR|PLD3|PLEKHA4|PLEKHF1|PLEKHG2|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|PLVAP|PNKP|PNMA8A|PNMA8B|PNPLA6|PODNL1|POLD1|POLR1G|POLR2E|POLR2I|POLRMT|POP4|POU2F2|PPAN|PPAN-P2RY11|PPFIA3|PPM1N|PPP1R12C|PPP1R13L|PPP1R14A|PPP1R15A|PPP1R37|PPP2R1A|PPP5C|PPP5D1|PPP6R1|PRAM1|PRDX2|PRG1|PRKACA|PRKCG|PRKCSH|PRKD2|PRMT1|PRODH2|PROSER3|PRPF31|PRR12|PRR19|PRR22|PRRG2|PRSS57|PRTN3|PRX|PSENEN|PSG1|PSG11|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG9|PSMC4|PSMD8|PSPN|PTBP1|PTGER1|PTGIR|PTH2|PTOV1|PTOV1-AS2|PTPRH|PTPRS|PVR|PWWP3A|QPCTL|QTRT1|R3HDM4|RAB11B|RAB3A|RAB3D|RAB4B|RAB8A|RABAC1|RAD23A|RANBP3|RASAL3|RASGRP4|RASIP1|RAVER1|RAX2|RBM42|RCN3|RDH13|RDH8|REEP6|RELB|RETN|REX1BD|REXO1|RFPL4A|RFPL4AL1|RFX1|RFX2|RFXANK|RGL3|RGS9BP|RHPN2|RINL|RLN3|RNASEH2A|RNF126|RPL13A|RPL18|RPL18A|RPL28|RPL36|RPS11|RPS15|RPS16|RPS19|RPS28|RPS5|RPS9|RRAS|RSPH6A|RTBDN|RTN2|RUVBL2|RYR1|S1PR2|S1PR4|S1PR5|SAE1|SAFB|SAFB2|SAMD1|SAMD4B|SARS2|SAXO5|SBK2|SBNO2|SBSN|SCAF1|SCAMP4|SCGB2B2|SCN1B|SDHAF1|SELENOV|SELENOW|SEMA6B|SERTAD1|SERTAD3|SF3A2|SGTA|SH2D3A|SH3GL1|SHANK1|SHC2|SHD|SHFL|SHISA7|SHKBP1|SIGLEC10|SIGLEC11|SIGLEC12|SIGLEC14|SIGLEC5|SIGLEC6|SIGLEC7|SIGLEC8|SIGLEC9|SIGLECL1|SIN3B|SIPA1L3|SIRT2|SIRT6|SIX5|SLC17A7|SLC1A5|SLC1A6|SLC25A23|SLC25A41|SLC25A42|SLC27A1|SLC35E1|SLC39A3|SLC44A2|SLC5A5|SLC6A16|SLC7A10|SLC7A9|SLC8A2|SMARCA4|SMG9|SMIM17|SMIM24|SMIM7|SNAPC2|SNRNP70|SNRPA|SNRPD2|SPACA4|SPC24|SPHK2|SPIB|SPINT2|SPMAP2|SPPL2B|SPRED3|SPTBN4|SRRM5|SSBP4|SSC5D|STAP2|STK11|STRN4|STX10|STXBP2|SUGP1|SUGP2|SULT2A1|SULT2B1|SUPT5H|SWSAP1|SYCE2|SYCN|SYDE1|SYMPK|SYNE4|SYNGR4|SYT3|SYT5|TARM1|TBC1D17|TBCB|TBXA2R|TCF3|TDRD12|TEAD2|TECR|TEKTIP1|TEKTL1|TEX101|TFPT|TGFB1|TGFBR3L|THAP8|THOP1|TICAM1|TIMM13|TIMM29|TIMM44|TIMM50|TINCR|TJP3|TLE2|TLE5|TLE6|TM6SF2|TMC4|TMED1|TMEM143|TMEM145|TMEM147|TMEM150B|TMEM160|TMEM161A|TMEM190|TMEM205|TMEM221|TMEM238|TMEM259|TMEM38A|TMEM59L|TMEM86B|TMEM91|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TNNI3|TNNT1|TNPO2|TOMM40		See cases	VCV000443498	19	260912 - 58956888			443498	437160			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 19q13.31-13.32(chr19:44300416-45639540)x1	APOC1|APOC2|APOC4|APOE|BCAM|BCL3|CBLC|CEACAM16|CEACAM19|CEACAM20|CLASRP|CLPTM1|GEMIN7|IGSF23|LYPD5|NECTIN2|PPP1R37|PVR|RELB|TOMM40|ZNF112|ZNF155|ZNF180|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF283|ZNF284|ZNF285|ZNF296|ZNF404|ZNF45		See cases	VCV000442437	19	44300416 - 45639540			442437	436099			copy number loss		Uncertain significance	Feb 16, 2015	no assertion criteria provided							
GRCh37/hg19 19q13.32(chr19:45284576-45978239)x3	APOC1|APOC2|APOC4|APOE|BCAM|BLOC1S3|CBLC|CKM|CLASRP|CLPTM1|ERCC1|ERCC2|EXOC3L2|FOSB|GEMIN7|KLC3|MARK4|NECTIN2|NKPD1|POLR1G|PPP1R13L|PPP1R37|RELB|TOMM40|TRAPPC6A|ZNF296		See cases	VCV000253776	19	45284576 - 45978239			253776	248224			copy number gain		Uncertain significance	Jan 20, 2016	criteria provided, single submitter							
GRCh37/hg19 19q13.2-13.32(chr19:43013365-47241534)x1	APOC1|APOC2|APOC4|APOE|BCAM|BCL3|BLOC1S3|CADM4|CALM3|CBLC|CCDC61|CCDC8|CD177|CEACAM1|CEACAM16|CEACAM19|CEACAM20|CEACAM8|CKM|CLASRP|CLPTM1|DACT3|DMPK|DMWD|EML2|ERCC1|ERCC2|ETHE1|EXOC3L2|FBXO46|FOSB|FOXA3|GEMIN7|GIPR|GNG8|GPR4|HIF3A|IGFL1|IGFL2|IGFL3|IGFL4|IGSF23|IRF2BP1|IRGC|IRGQ|KCNN4|KLC3|LYPD3|LYPD5|MARK4|MYPOP|NANOS2|NECTIN2|NKPD1|NOVA2|OPA3|PGLYRP1|PHLDB3|PINLYP|PLAUR|PNMA8A|PNMA8B|POLR1G|PPM1N|PPP1R13L|PPP1R37|PPP5C|PPP5D1|PRG1|PRKD2|PSG1|PSG11|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG9|PTGIR|PVR|QPCTL|RELB|RSPH6A|RTN2|SIX5|SMG9|SNRPD2|SRRM5|STRN4|SYMPK|TEX101|TOMM40|TRAPPC6A|TRU-TCA1-1|VASP|XRCC1|ZNF112|ZNF155|ZNF180|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF283|ZNF284|ZNF285|ZNF296|ZNF404|ZNF428|ZNF45|ZNF575|ZNF576		See cases	VCV000253540	19	43013365 - 47241534			253540	247988			copy number loss		Pathogenic	Jan 20, 2016	criteria provided, single submitter							
